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The inappropriate use of antibiotics in the veterinary sector has led to antibiotic resistance (ABR), 
which negatively impacts animal health and welfare and indirectly on human health. Understanding 
the knowledge, attitudes, and practices on antibiotic use, ABR, and its containment amongst 
veterinarians is critical to optimize antibiotic use and contain resistance. A quantitative questionnaire-
based online survey was conducted amongst members of professional veterinary associations. The 
questionnaire consisted of four sections focusing on socio-demographic characteristics, knowledge, 
attitudes, and practices (KAP) of participants on antibiotic use, ABR, and its containment in the South 
African veterinary sector. The Independent t-test, analysis of variance (ANOVA), and Chi-square test 
were used to establish associations among selected socio-demographic variables and selected KAP 
parameters. A total of 130 responses were received from 2178 animal health professionals, yielding a 
response rate of 6 %, with 102 complete responses constituting the final sample size. Self-reported 
knowledge on antibiotic stewardship, antibiotic resistance mechanisms, and pharmacology was good 
at 96 (94.1%), 91 (89.2%), and 70 (68.6%), respectively. More than half the respondents (60 [58.8%]) 
were confident that the veterinary training they received prepared them quite a bit/very much on 
rational antibiotic use. Most respondents (81 [79.4%]) believed that antibiotics were sometimes 
prescribed for suspected but not confirmed infections. The majority of the respondents (77 [75.5%]) 
were quite concerned/very concerned about antibiotic resistant infections, compared to 19 (18.7%) of 
clients expressing the same concern. Veterinary guidelines for appropriate use of antibiotics were 
sometimes read by respondents (45 [44.1%]). A little more than half of the veterinarians (54 [52.9%]) 
often/always discussed antibiotic resistance with their clients. Most respondents identified broad-
spectrum antibiotics such as amoxicillin-clavulanate and metronidazole as first-line treatment at 62 
(60.8%) and 64 (62.7%) respectively. Notably, most of the veterinarians (61 [59.8%]) also lacked an 
antibiotic stewardship programme at their practice. The cost of diagnostics (90 [88.2%]), time to 
results of diagnostics (83 [81.4%]), and client expectations of receiving antibiotics (74 [72.5%]) were 
cited amongst barriers to the implementation of an antibiotic stewardship programme.  Place of 
practice was significantly associated (p=0.004) with possession of knowledge about antibiotic 
resistance. Veterinarians in urban practice were more knowledgeable about antibiotic resistance than 
those in rural practice. Place of practice was also significantly associated (p=0.035) with discussions 
on antibiotic resistance with clients. More veterinarians in rural practice frequently carried out such 
discussions than their urban counterparts. There is a need for education and training to address gaps in 
KAP. There is also a need for the development and implementation of antibiotic stewardship 
programmes in veterinary practice. Cost effective diagnostic tests with shorter turnaround time might 
assist in achieving such. The programmes might encourage microbiology informed therapy and the 




                                                 INTRODUCTION AND LITERATURE REVIEW 
 
1.1 INTRODUCTION 
The use of antibiotics in animals has contributed immensely in the fight against infectious 
diseases. Use has been beneficial in various ways including (1) alleviating pain and suffering, 
(2) controlling potential epidemics that may cause colossal animal losses, (3) mitigating the 
spread of zoonotic bacteria, (4) ensuring the sustainability of food animal production and, (5) 
protecting people’s livelihoods and animal resources (Michigan State University, 2011). 
Antibiotics have been used for therapeutic purposes, prophylaxis, metaphylaxis, and growth 
promotion. Veterinarians are key stakeholders in containing ABR in animal health. They are 
trained to diagnose infections and prescribe antibiotics if warranted. Veterinarians ensure that 
the authorized withdrawal time for antibiotics is adhered to and are key to educating their clients 
on the rational use of antibiotics and the containment of ABR. Before antibiotics are 
administered, treatment guidelines that ensure the appropriate use of antibiotics considered to be 
of critical importance in veterinary medicine and human health should be adhered to (Murphy et 
al., 2017). However, antibiotic misuse and overuse contribute to antibiotic resistance (ABR), a 
worrying threat to human and animal health the world over (FAO, 2019; OIE, 2016).  
 
The consequences of ABR impact negatively on the welfare of animals. The animals will 
endure pain and suffering from ‘difficult-to-treat” or untreatable infections. The damage to 
tissues and organs that might occur can be irreversible, and death can occur in some instances. 
ABR also has a socio-economic and emotional bearing on animal owners due to non-resolving 
infections in animals. For animal producers, non-resolving infections lead to poor feed 
conversion, decreased growth, increased mortality, and reduced productivity (Vaarten, 2012). 
By 2050, an 11% drop in animal productivity is set to occur due to ABR (World Bank, 2017). 
ABR will also encourage the use of newer, effective antibiotics after the failure of first-line 
antibiotics, thus broadening the list of ineffective antibiotics. The lack of effective antibiotics 
will also cause much faster dissemination of zoonotic bacterial organisms and a huge potential 
for disease outbreaks at a large scale. Such outbreaks will be very costly to control. The lack of 
advancement of new veterinary antibiotics is of huge concern (Vaarten, 2012), yet, animal 
production as a contributor to ABR, continues to intensify, thus escalating antibiotic use. Such 
an escalation is due to a growing demand for animal protein world over (FAO, 2019). Animal 
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health is under threat from the ever increasing ABR (FAO, 2016). To preserve the antibiotics 
that are still effective and prevent ABR from further worsening in animal health, educators, 
professional bodies, governments, and animal health stakeholders need to mitigate ABR 
effectively (O’Neill, 2016). 
 
In a tripartite alliance, the World Organisation for Animal Health (OIE), the Food and 
Agriculture Organisation (FAO) of the United Nations, and the World Health Organisation 
(WHO) developed the Global Action Plan (GAP) to address AMR which was adopted in May 
2015 by the World Health Assembly (WHO, 2015). The alliance recognises the interrelatedness 
of human, animal, and environmental health hence the need for such an alliance to effectively 
control ABR. In support of GAP, the World Organisation for Animal Health (OIE) and the Food 
and Agriculture Organisation (FAO) of the United Nations have since rolled out their action 
plans to curb ABR. They both support member states in the development and implementation of 
strategies to curb ABR in animals and the food and agriculture sectors, respectively (FAO, 
2016; OIE, 2016).   
 
Animal health professionals have to possess the necessary knowledge to improve attitudes and 
practices on antibiotic use, antibiotic resistance, and its containment. Knowledge,  attitude and 
practices are core to behavioural change. Assessing animal health professionals on knowledge, 
attitudes, and practices on antibiotic use, antibiotic resistance, and its containment is, therefore, 
necessary in order to inform evidence-based interventions. Such evidence-based interventions 
could curb the emergence and dissemination of ABR, thereby improving animal welfare, 
sustaining animal production, and safeguarding the future of veterinary medicine and human 
medicine. 
 
1.2 LITERATURE REVIEW 
1.2.1 Antibiotics 
Antibiotics are substances that are used therapeutically for bacterial infections. They work by 
inhibiting or killing bacteria (Boolchandani, D’Souza and Dantas, 2019). Antibiotics can be 
classified based on chemical structure, mechanism of action (Table 1.1) or spectrum of activity 
(Calderon and Sabundayo, 2007). Based on chemical structure, the common antibiotic classes 
include β-lactams, aminoglycosides, tetracyclines, quinolones, macrolides, sulphonamides, 
oxazolidones, amphenicols, rifamycins, streptogramins, polymyxins, pleuromutilins and 
glycopeptides (Löfmark, Edlund and Nord, 2010; Fair and Tor, 2014; Adzitey, 2015). 
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Antibiotics can be bactericidal. These kill bacteria, e.g., penicillins, cephalosporins, 
carbapenems, monobactams, glycopeptides, fluoroquinolones, rifamycins, cyclic lipopeptides, 
aminoglycosides, and streptogramins. Antibiotics can also be bacteriostatic, e.g., sulfonamides, 
trimethoprim, tetracyclines, chloramphenicol, and clindamycin. These  inhibit bacterial growth. 
Some classes can be bacteriostatic and bactericidal, e.g., macrolides (Calderon and Sabundayo, 
2007). The mechanism of action of an antibiotic influences whether an antibiotic is bactericidal 




Table 1.1: Antibiotic classes and their mechanisms of action 
 
Antibiotic class Examples Mechanism of action 
Sulphonamides sulfadiazine 
 
Inhibit an enzyme crucial to the metabolism of folic acid (dihydropteroate synthetase), leading to 
suppressed DNA replication. Sulphonamides are bacteriostatic against both aerobic Gram-positive and 








Inhibit cell wall synthesis by attaching to the penicillin-binding protein site transpeptidase (Beauduy 
and Winston, 2018). Peptide chain cross linkage, which is crucial for peptidoglycan formation, is 
hindered, leading to the bacterial cell’s death (Bush, 2018). 
Aminoglycosides amikacin Causes protein mistranslation by commonly targeting the A site of the 16S ribosomal RNA component 
of the 30S ribosomal subunit (Fair and Tor, 2014).  
Amphenicols chloramphenicol Affect translation by inhibiting elongation through binding of the 50S ribosomal subunit’s peptidyl 
transferase centre (Fair and Tor, 2014). 
Macrolides tulathromycin Cause premature peptidyl transfer RNA separation from the ribosome, thereby preventing elongation in 
translation upon binding the 50S ribosomal subunit (Tenson, Lovmar and Ehrenberg, 2003).  
Tetracyclines tetracycline 
doxycycline 
Block aminoacyl transfer RNA ribosomal access upon binding to the 30S ribosomal unit. Tetracyclines 
are bacteriostatic and broad-spectrum in nature (Fair and Tor, 2014).  
Rifamycins rifampicin Inhibit transcription through binding the RNA polymerase β-subunit (Fair and Tor, 2014).  
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Antibiotic class Examples Mechanism of action 
Glycopeptides vancomycin Binds the peptidoglycan units’ terminal dipeptide D-Ala-D-Ala which inhibits their function as 
transglycosylase and penicillin-binding protein substrates, thereby inhibiting cell wall biogenesis in 
Gram-positive bacteria (Fair and Tor, 2014). 
Quinolones ciprofloxacin 
 
Inhibit DNA synthesis by trapping enzymes responsible for DNA cleavage following the inhibition of 
topoisomerases II and IV (Drlica et al., 2008). Quinolones are bactericidal (Kohanski, Dwyer and 
Collins, 2010).  
Streptogramins dalfopristin  
quinupristin  
They are divided into two classes according to structural basis. Class A streptogramins inhibit 
translocation and initiation upon binding the 50S ribosomal unit’s peptidyl transferase centre. In 
contrast, class B streptogramins inhibit elongation in translation through binding to the tunnel of 
peptide exit (Fair and Tor, 2014). Combinations of both classes are usually bactericidal. When used 
alone, they are bacteriostatic (Kohanski, Dwyer and Collins, 2010). 
Polymyxins polymyxin B 
colistin 
 
Cause a disruptive interlinkage with the Gram-negative lipopolysaccharide outer layer on the cell 
membrane, resulting in increasing cell membrane permeability, leakage and death of the cells (Evans, 
Feola and Rapp, 1999).  
Oxazolidinones linezolid Block the formation of the peptide bond by binding to the 50S ribosomal unit peptidyl transferase 
centre. Oxazolidinones are bacteriostatic against Gram-positive bacteria (Fair and Tor, 2014). 
Pleuromutilins tiamulin Inhibit translation by binding the 50S ribosomal unit peptidyl transferase centre (Fair and Tor, 2014). 
Nitroimmidazoles metronidazole Inhibit the synthesis of DNA, also cause DNA oxidation leading to the degradation of DNA and death 
of cells (Löfmark, Edlund and Nord, 2010) 
Phosphonic acid 
derivatives 
fosfomycin Interfere with a crucial step in bacterial cell wall synthesis by inhibiting an enzymatic reaction. They 
have bactericidal activity (Skarzynski et al., 1996). 
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1.2.2 Antibiotic resistance 
ABR occurs when bacteria continue to survive and grow regardless of the presence and/or 
pressures posed by antibiotics that were initially effective in managing the infections. In most 
cases, ABR is encoded genetically in bacteria (Boolchandani, D’Souza and Dantas, 2019). In 
bacteria, two types of resistance have been observed. These are intrinsic and acquired resistance 
(Alekshun and Levy, 2007).  
 
Chromosomal genes occurring naturally in a bacterial host mediate intrinsic resistance 
(Alekshun and Levy, 2007). Intrinsic resistance is usually shared among organisms of the same 
genus or species (Courvalin, 2008). It often happens via biochemical or structural properties that 
are characteristic of the organism. Such is the case in many Gram-negative organisms which are 
resistant to macrolides. The macrolides are excessively large to access their target in the 
cytoplasm through the outer membrane (Boerlin and White, 2006).  
 
In acquired resistance, a bacterial organism that is usually susceptible to an antibiotic undergoes 
genetic alteration leading to resistance. Such can occur through mutation in genes responsible 
for normal cellular structures and physiology or the acquisition of alien resistance genes. A 
combination of both processes can also lead to antibiotic resistance. The acquisition of  foreign 
DNA that codes for resistance can occur in three processes which are:  
1. Transformation, whereby naked DNA in the environment is taken in by bacteria which 
naturally possess such capacity,  
2. Transduction, whereby DNA is transferred between bacteria by bacteriophages, and  
3. Conjugation, whereby plasmids are transferred from one bacterium to another via a 
mating like process (Boerlin and White, 2006).  
 
The movement of genes coding for resistance is also possible within a bacterial cell genome. 
Various resistance gene combinations can occur through the movement of resistant genes 
between chromosomes and plasmids with transposons and integrons playing a crucial role. 
Acquired resistance can present as resistance to the whole antibiotic class, resistance to 
antibiotics of various classes or resistance to several antibiotics within the same class. In most 
cases, resistance can be encoded to one or more antibiotics of the same class by a single 
resistance determinant as observed in fluoroquinolones, β-lactams, or aminoglycosides, e.g., 
antibiotic inactivating enzymes. It is also possible to have resistance encoded to multiple 
antibiotic classes by a single resistance determinant, e.g. efflux. A bacterial cell can also 
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simultaneously acquire various resistance determinants leading to multidrug resistance (Boerlin 
and White, 2006). 
Four mechanisms of antibiotic resistance exist, which are (1) active efflux of drug, (2) limited 
drug uptake, (3) drug target modification, and (4) drug inactivation. The structural variation 
between Gram-positive and Gram-negative bacteria influences the antibiotic resistance 
mechanisms. Gram-positive bacteria infrequently employ limited drug uptake due to lack of 
capacity to carry out some of the efflux mechanisms and lack of a lipopolysaccharide outer 
membrane. In contrast, Gram-negative bacteria displays all four mechanisms (Reygaert, 2018). 
 
Bacterial cells make use of efflux pumps to maintain normal physiology, which includes 
expelling toxic waste. Efflux pumps are genetically encoded on the bacterial chromosomes, and 
efflux pump genes may be expressed in specific environmental conditions such as the presence 
of antibiotics. Antibiotic efflux enables bacterial survival in conditions of high antibiotic 
concentration. Efflux pump overexpression is capable of causing antibiotic resistance of clinical 
relevance in Gram-negative bacteria (Blair, Richmond and Piddock, 2014). Several efflux pump 
families exist and are classified according to structure and source of energy (Reygaert, 2018). 
The resistance nodulation division (RND) family is of clinical relevance in Gram-negative 
bacteria (Blair, Richmond and Piddock, 2014). One example is the AcrAB-TolC efflux pump in 
Escherichia coli capable of transporting β-lactams, fluoroquinolones, erythromycin, 
tetracycline, linezolid and chloramphenicol, among other compounds (Ma et al., 1993; Okusu, 
Ma and Nikaido, 1996; White et al., 1997). Such an ability to transport a wide range of 
antibiotics allows resistance to different antibiotic classes (Du et al., 2014). In Gram-positive 
bacteria, an example of active efflux pumps is the NorA pump under the major facilitator 
superfamily (MFS) in Staphylococcus aureus responsible for chloramphenicol and 
flouroquinolone efflux (Reygaert, 2018). 
  
The Gram-negative lipopolysaccharide layer provides a crucial role in limiting drug uptake as it 
is a barrier for some molecules. It provides intrinsic resistance to some antibiotics (Blair, 
Richmond and Piddock, 2014). Polar molecules do not easily pass the cell wall in enterococci, 
thus conferring intrinsic resistance to aminoglycosides. Mycoplasma lacks a cell wall, thus 
limiting the uptake of antibiotics with a cell wall target. Such a structural characteristic confers 
intrinsic resistance (Bébéar and Pereyre, 2005). Gram-negative bacteria have an outer 
membrane and use the porin channels which allow the entry of hydrophilic substances 
(Fernández and Hancock, 2012). However, drug uptake can be limited through mutations that 
can affect porin selectivity/size, or a reduction in porin numbers can take place (Kumar and 
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Schweizer, 2005). Bacteria have also been known to form communities on solid surfaces 
protected by a matrix of polysaccharides. These bacterial communities are termed biofilms. The 
matrix provides a barrier to antibiotics thus limiting uptake (Mah, 2012). 
 
Bacteria can modify antibiotic targets, thereby conferring resistance (Reygaert, 2018). One 
example is Gram-positive bacteria’s ability to confer resistance to β-lactams by altering 
penicillin-binding protein numbers and or structure. Penicillin-binding proteins are necessary 
for peptidoglycan construction. Changes in penicillin-binding protein numbers have a negative 
impact on the amount of β-lactam binding the target. Structural changes to the target decrease 
the binding ability of β-lactams. Such changes also have the potential to inhibit β-lactam 
binding completely. Another example is decreased susceptibility of S. aureus to vancomycin 
following mutations that result in increased thickness of the cell wall, thus limiting vancomycin 
access to the peptidoglycan target. Gene acquisition (van genes) can also cause structural 
changes in the precursors to the peptidoglycan layer, thus reducing vancomycin binding ability 
(Beceiro, Tomás and Bou, 2013). Bacteria can also modify ribosomal subunit targets affecting 
drug binding ability to the ribosome. It can happen either through methylation conferring 
resistance to lincosamides and macrolides or by mutation, thus conferring resistance to 
streptogramins and macrolides (Roberts, 2004). Nucleic acid synthesis targets can also be 
modified through mutation, e.g, genes coding for DNA gyrase and topoisomerase IV 
(fluoroquinolone targets), affecting drug binding ability confer resistance to fluoroquinolones 
(Redgrave et al., 2014). Enzyme mutation can also affect drugs such as sulphonamides and 
trimethoprim. Structural alterations in the enzymes interfere with antibiotic binding leading to 
resistance. Both drugs act as competitive inhibitors by binding to the enzymes dihydropteroate 
synthase and dihydrofolate reductase, respectively, crucial for folic acid metabolism (Sköld, 
2010).  
 
Bacterial cells can carry out antibiotic inactivation either by transferring a chemical group or 
through antibiotic degradation (Blair et al., 2015). Phosphate, adenyl and acetyl groups are 
among the groups that can be enzymatically transferred to an antibiotic. Antibiotics that can be 
affected by acetylation include fluoroquinolones, chloramphenicol and aminoglycosides 
(Robiscek et al., 2006; Ramirez and Tolmasky, 2010). Antibiotic degradation can occur through 
hydrolysis. Both Gram-positive and Gram-negative bacteria are known to produce β-lactamases, 
a group of enzymes that can hydrolyse the amide bond in β-lactam antibiotics (Bush, 2018). 
This opens the β-lactam ring making the drug unable to bind to the penicillin-binding protein 
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target (Reygaert, 2018). β-lactamases can be located on the chromosome or acquired through 
plasmids (Schultsz and Geerlings, 2012). 
 
It is worth noting that several antibiotics appear under two or more resistance mechanisms. One 
likely explanation for such a scenario is the bacterial evolution that has happened over the years 
to survive antibiotic effects. Bacterial genome plasticity that enables horizontal gene transfer 
and mutations has made it possible (Munita and Arias, 2016). Therefore, it is necessary to create 
new antibiotics putting in mind the versatility shown by bacteria (Reygaert, 2018). Knowledge 
of antibiotic classifications, mechanisms of action, spectrum of activity and mechanisms of 
resistance is imperative among veterinarians. Such knowledge will ensure the maintenance of 
antibiotic efficacy and animal health while simultaneously minimising the risk of antibiotic 
resistance occurrence.  
 
The risk of antibiotic resistance emergence can be reduced by managing bacterial contaminants, 
creating a dosing regimen, and de-escalating. Managing bacterial contaminants in the veterinary 
health facility and the farm environment reduces the dissemination of bacteria with resistance 
potential. De-escalation involves reducing antibiotic spectrum (Schulz, Osterby and Fox, 2013). 
Antibiotic use increases selection pressure for antibiotic resistance; therefore, it is necessary to 
minimise use where possible. Microbial culture and susceptibility testing may help identify a 
causative agent and its susceptibility profile hence encouraging narrow-spectrum antibiotic use 
(Weese et al., 2015). Education on antibiotic stewardship, assessment of antibiotic prescriptions 
during therapy and the use of automated clinical decision support tools that assist veterinarians 
in antibiotic prescribing may facilitate appropriate antibiotic use (Schulz, Osterby and Fox, 
2013). Local treatment of abscesses and topical treatment of skin infections should be 
considered as opposed to systemic antibiotic therapy in such cases. Antibiotic therapy should 
also be given for the shortest possible duration of therapy. A dosing regimen should be designed 
so that the choice of antibiotic in an infection eliminates the bacterial inoculum. The causative 
agent should be identified and characterised, and susceptibility testing should be done to match 
the drug choice and causative agent effectively. Upon identifying the antibiotics that are 
effective against the bacterial isolates, the veterinarian should consider host and bacterial 
responses in choosing the antibiotic that can reach the affected tissue (Boothe, 2015). 
1.2.3 Antibiotic Resistance and One Health 
Antibiotic use and overuse in the animal and human sectors, antibiotic disposal into the 
environmental sector and the dissemination of resistant organisms and determinants within and 
between the sectors globally has made ABR a One Health issue. One Health refers to the joint 
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efforts of professions in animal health, human health, and environmental sectors to achieve the 
best possible health in animals, humans and the environment. The One health approach 
recognises the interrelatedness of the animal, human and environmental sectors in antibiotic 
resistance (McEwen and Collignon, 2017). 
 
ABR occurs naturally. However, antibiotic use in agriculture, industries, and human health 
creates a selection pressure favouring the existence of resistance genes or resistant bacterial 
strains above the antibiotic susceptible strains. The result is an increased load of resistant 
organisms in the environment. The ABR emergence rate in humans and animals depends on the 
antibiotic amounts used together with the exposure frequency and duration (Wall et al., 2016).  
 
Evidence on the link between antibiotic use in animals and ABR in humans  has been 
demonstrated. In the year 2000, the US Food and Drug Administration proposed the withdrawal 
of fluoroquinolone use following an increase in fluoroquinolone-resistant Campylobacter 
associated human infections linked to poultry consumption. This was then followed by the 
effective withdrawal of enrofloxacin use in poultry in 2005 in the US. Fluoroquinolones are 
among the choice for treatment against Campylobacter infections in humans, while use is also 
common in veterinary medicine (Nelson et al., 2007). In Denmark, E. coli isolates were 
collected from poultry, pigs, cattle, and meat products and compared to the same isolates from 
human urinary tract infections and healthy individuals. Upon comparing the virulence genes, 
pulse-field gel electrophoresis, phylotypes, and antimicrobial susceptibility results, a clonal link 
was observed between E. coli from humans and animals or their meat products (Bager et al., 
2016). In Canada, a study was carried out to underscore the relationship between ceftiofur-
resistant Salmonella heidelberg isolated from retail chicken and the occurrence of ceftiofur-
resistant S. heidelberg human infections. Prior to data analysis with a statistical package, the 
isolates from retail chicken and humans underwent serotyping, phage typing, and susceptibility 
testing. A positive correlation between isolates from retail chickens and the incidence of human 
infections caused by ceftiofur resistant S. heildelburg throughout Canada was observed. The 
study also observed that the ceftiofur resistant patterns in chicken and human S. heidelberg were 
directly linked to the level of ceftiofur usage in broiler chicken hatcheries. Resistant rates for 
human and chicken isolates diminished after ceftiofur use was interrupted in 2005 and increased 
after the antibiotic was reintroduced in the hatcheries in 2007 (Dutil et al., 2010).  
 
The human demand for animal protein-based diets has been on the rise world over. This has led 
to a rise in intensive animal production systems that require the frequent use of antibiotics to 
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support productivity and maintain animal health globally. This has a huge potential to increase 
bacterial selection pressure (Van Boeckel et al., 2015). In such establishments, optimal disease 
prevention measures such as correct vaccination, biosecurity, and proper husbandry measures 
such as the correct feeding of animals, proper housing, and correct management practices are 
necessary. Such measures will ensure the minimal use of antibiotics as the likelihood of disease 
risks will be reduced (Magnusson et al., 2019). However, such measures may not be efficiently 
practised and implemented as they can be very costly.  
1.2.4 Growth Promotion, Prophylaxis and Metaphylaxis 
The use of antibiotics in growth promotion, prophylaxis, metaphylaxis, and therapy has been 
associated with ABR (Wall et al., 2016). Antibiotic use in growth promotion involves 
administering antibiotics for a prolonged time in healthy livestock. Such a practise aims to boost 
the capacity in the conversion of feed into body mass thus promoting growth (Doyle et al., 
2006). Antibiotic growth promoters consist of animal feed with antibiotics in subtherapeutic 
levels. Regardless of the inconsistent results on whether antibiotic growth promoters lead to the 
significant enhancement of growth in animals (Lee et al., 2012), the application of antibiotic 
growth promoters in food animal production has been practiced the world over to enhance 
growth since as early as the 1950s (Wielinga et al., 2014). However, it was observed that the 
use of sub-therapeutic levels of antibiotics in animal feed brings an alteration to the gut 
microbes of treated animals, which encourages the transmission of resistance into the 
environment via animal waste (You and Silbergeld, 2014). After concerns were raised on the 
effects of antibiotic growth promoters on the emergence and dissemination of resistance in 
livestock, antibiotic growth promoters were banned in the European Union in 2006 (Murphy et 
al., 2017).  
 
Even though antibiotic growth promoters have diminished in some parts of the world, use is still 
evident in animal production in some countries. According to the third annual OIE report on 
antibiotics for animal use, data collected between 2015 and 2017 through a data template 
indicated that 110 of the 155 countries that responded did not use antibiotic growth promoters as 
of 2017. However, the remaining 29% (45 out of 155) reported the use of antibiotic growth 
promoters. It was noted that colistin, an antibiotic that is reserved for treatment in serious 
infections in human beings, was being used in growth promotion in some countries (Gochez et 
al., 2018), thus posing a huge public health risk.  
 
The prophylactic use of antibiotics involves administering antibiotics to healthy, susceptible 
animals to prevent infectious diseases from occurring. Prophylactic antibiotic use has the 
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potential to produce the same effects as antibiotic growth promoters. Therefore, it is imperative 
to follow the correct therapeutic dosage which minimally induces resistance in the affected 
bacteria. However, administering antibiotics to groups of animals via feed and water might 
create a different picture altogether since the animals exposed and the amounts of antibiotics 
consumed might vary. In such scenarios, sub-optimal dosing might occur, thereby increasing the 
risk of ABR emerging (Wall et al., 2016).   
 
Metaphylaxis involves administering antibiotics to all animals in a group at therapeutic doses 
after some of them show signs of an infection. Metaphylaxis acts in both ways, therapeutic for 
infected animals and preventive for animals who are at risk of contracting an infection in the 
group. In metaphylaxis, the number of animals that can be exposed to antibiotics can be vast. 
This creates a huge potential for resistance to emerge as bacteria possessing natural resistance 
have a high chance of being selected for (Wall et al., 2016).  
 
Therapeutic antibiotic use involves the use of antibiotics in the management of an active 
bacterial infection in one or more animals. The continuous therapeutic use of antibiotics in the 
case of recurrent infections in an animal increases the chances of ABR emergence in resident 
bacterial populations in that particular animal (Usui, Uchida and Tamura, 2014). There is a 
tendency to use broad-spectrum antibiotics in the treatment of animals prior to or as the 
preference to a confirmed diagnosis (Wall et al., 2016), this is known to promote ABR 
development and spread (Kardos, 2017). 
 
Bacterial resistance that results from veterinary antibiotic use can cause resistance to drugs of 
the same class used in human medicine, thus contributing to therapeutic failure in humans. 
Therefore, veterinarians must be knowledgeable about resistance potential in the selection of 
drug therapy for food animals. Client education is also necessary on the contribution of growth 
promoters and antibiotic use in intensive production setups to antibiotic resistance (Boothe, 
2015). 
1.2.5 Antibiotic resistance containment strategies 
In a tripartite alliance, the World Health Organisation (WHO), the World Organisation for 
Animal Health (OIE), and the Food and Agriculture Organisation (FAO) of the United Nations 
developed the Global Action Plan (GAP) on Antimicrobial Resistance (AMR). In May 2015, 
the World Health Assembly adopted the GAP. The plan supplies the supporting structure for 




1.2.5.1 Selected FAO initiatives from 2012 to date 
The Food and Agriculture Organisation has been involved in various strategies to manage ABR 
in the food and agriculture sector. The organisation’s mandate is to guide global attempts in 
reducing hunger. Antibiotics are crucial in maintaining the health of food animals. Food animal 
production sustains livelihoods and the development of economies world over. In 2012, the 
organisation commemorated World Veterinary Day by renewing a call to appropriate antibiotic 
use in food animal production to maintain antibiotic efficacy in veterinary and human health 
(FAO, 2012).  
  
In support of GAP, members of FAO took up Resolution 4/2015 at a FAO conference in June 
2015. The resolution is an appeal to the organisation itself and member states to deal with the 
food and agriculture sectors’ contributions to the ABR threat and its impact thereof. The 
resolution was envisaged to be implemented by way of an action plan which focuses on four 
key areas (FAO, 2016). 
 
        Key area 1: Improving ABR awareness and its associated threat 
ABR awareness among veterinarians, para-veterinarians, and all other stakeholders in the food 
chain is necessary for behavioural change. The action plan states that awareness will be 
improved through the development of communication tools that target veterinary personnel. The 
FAO will support member countries in developing, adapting, and distributing such 
communication tools to food and agriculture audiences. Deliberation on ABR will also be 
consolidated into discussions on policy in food and agriculture through partnering with WHO, 
OIE, and others in national, regional, and global public awareness events. Published progress 
reports on Action Plan implementation are also set to contribute to ABR consolidation in 
policy-level discussions in the food and agriculture sectors (FAO, 2016). 
 
In a bid to raise awareness on ABR among stakeholders in the food and agriculture sectors, 
health workers, policymakers, and the general public, FAO, OIE and WHO have since 2015 
dedicated a week in November of each year to commemorate World Antibiotics Awareness 
Week (WAAW) the world over. FAO has been involved in supporting member states to foster 
behaviour change, thus preventing the emergence and dissemination of ABR in the food and 
agricultural sector, health sector, and the environment (FAO, 2020a). FAO is also involved in 





         Key area 2: developing capacity for surveillance and monitoring of ABR and use of       
                              antibiotics in food and agriculture sectors 
An understanding of the degree of antibiotic use and level of ABR allows the assessment of 
progress for measures put in place towards mitigating ABR. In partnership with WHO and OIE, 
FAO will support countries generating data on antibiotic use and ABR to encourage action 
locally. Knowledge on the use of antibiotics and ABR is expected to be improved through (1) 
the development of training materials on antibiotic use, ABR and associated surveillance and 
monitoring, (2) encouraging research focusing on improving knowledge on antibiotic use, ABR 
and its transference to humans, and, (3) assisting in the incorporation of antibiotic use and ABR 
as main foundations in undergraduate, postgraduate and continuing education (FAO, 2016).     
             
In 2017, FAO and the Indian Council of Agriculture Research organised a meeting in India to 
identify areas for policy formulation and development of programmes to address ABR. With a 
team of veterinary researchers, human health researchers, and facilitators from USAID and 
FAO, 25 research topics that were meant to increase knowledge and strengthen ABR mitigation 
responses were formulated. Among the areas included was identifying behavioural aspects of 
antibiotic use in animals (FAO, 2017). Knowledge influences behaviour hence the need for 
KAP studies on antibiotic use and ABR among animal health professionals. Such studies will 
help inform interventions on education and training of animal health professionals at the 
undergraduate and postgraduate levels.  
 
         Key area 4: promoting appropriate antibiotic use and good practices in food and   
                              agriculture systems.  
This area of focus seeks to support measures that reduce antibiotic use and prevent the 
dissemination of resistant organisms in the food and agriculture sectors. It also aims to ensure 
that knowledge on antibiotic use, ABR, and its related threats culminates into better practices 
among veterinarians, para-veterinarians, and other stakeholders in the food chain. This will be 
achieved by promoting the use of education and training materials that encourage appropriate 
antibiotic use, effective infection prevention, proper biosecurity measures, and ABR 
containment strategies. The use of internationally recognised guidelines and standards that focus 
on good practices in dealing with ABR will be adopted among member states (FAO, 2016).  
 
In 2018, FAO published the “Antimicrobial resistance policy review and development 
framework,” a guideline for Asia Pacific governments in reviewing, updating, and developing 
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policies on ABR and use of antibiotics in animal production. It aims to identify gaps in national 
policies on ABR and the use of antibiotics that can be improved by government agencies 
accordingly. Policy on ABR and antibiotics can be assessed on four areas adopted from the 
FAO action plan: awareness, practices, governance, and evidence. Governments of the member 
states should engage with veterinarians, and other animal health workers and evidence-based 
practices should be used in raising awareness. In this regard, existing policies on education and 
awareness on ABR need to be evaluated. Aspects that can be evaluated on policies include:  
1. The inclusion of ABR topics in undergraduate, graduate, postgraduate and continuing 
veterinary education,  
2. The availability of trainers to educate animal health stakeholders,  
3. Clarity, transparency, and accessibility of available policies on education and 
awareness, and  
4. The availability of human resources, teaching materials, and funding among others 
(FAO, 2018a). 
Gaps identified in policies will then provide opportunities for improvement in national actions. 
Such improvements will foster behaviour change on antibiotic use among animal health 
professionals and thus help preserve the remaining antibiotics. Effective ABR containment 
strategies are advocated in veterinary medicine. Animal welfare is maintained, and livelihoods 
will be safeguarded (FAO, 2018a).  
 To prevent the emergence of ABR, FAO has also partnered with the Swedish University of 
Agricultural Sciences to develop a manual that assists veterinarians in Eastern Europe, the 
Balkans, and Central Asia to improve their practices for appropriate antibiotic use. The 
partnership will also promote knowledge sharing and international training on ABR (FAO, 
2018b). In 2019, a manual entitled “Prudent and efficient use of antimicrobials in pigs and 
poultry” was then published. Targeting sectors with pronounced antibiotic use, the manual 
emphasizes on minimising antibiotic use through appropriate use and effective disease 
prevention. Appropriate antibiotic use involves:  
1. Use of the right dosage and duration,  
2. The use of an antibiotic following proper diagnosis by qualified animal health personnel 
where indications are authorised,  
3. Preventing the animal use of antibiotics deemed as critically important (CIAs) in human 
medicine and complying with the list of antibiotics of veterinary importance by the OIE 
and,  




Effective disease prevention involves appropriate vaccination, biosecurity, and good husbandry 
practices (Magnusson et al., 2019). 
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Table 1.2: Selected FAO initiatives raising knowledge and awareness on ABR and its related threats. 
 
Project title Period Target 
countries 
Objectives Achievements/ Expected outcomes References 
“Addressing 
Antimicrobial Usage 
















antibiotic use in 
livestock, aquaculture, 
and crop production in 
Asia. 
Awareness on the impact of AMR and best antibiotic use practices  
is expected to be raised through:  
• Development of KAP studies. 
• Data examination of KAP studies among stakeholders in the 
region to determine trends. 
• Training of relevant personnel in the communication of 
behavioural change and KAP study approach. 
• Creating campaigns and communication materials on AMR. 
• Celebrating the “World Antibiotic Awareness Week” 
annually, an event aimed to raise AMR understanding, 
motivate for appropriate antibiotic use, and good practices 
among professionals and the public world over.  




national strategy to 
reduce the threat of 
AMR in agriculture, 
fisheries, food, and 
livestock production 
as part of the 
implementation of 












dissemination in the 
food and agriculture 
sectors by assisting the 
targeted countries with 
the development of 
NAPs on AMR. 
• Awareness on AMR and its associated threats among 
stakeholder representatives in the food and agriculture sectors 
was raised. 
•  Insight on the existing knowledge and awareness together 
with policies and capacities on ABR and antibiotic use were 
improved in the target countries. 
• AMR and the use of antimicrobials were improved after being 
assessed. 
• Coordination in the implementation of a “One Health” 






Project title Period Target 
countries 
Objectives Achievements/ Expected outcomes References 
“Support the 
development of 
NAPs on AMR in 














Encouraging the food and 
agriculture sectors in the 
target countries to assist 
in developing NAPs on 
AMR. 
• The level of awareness of AMR’s threat and impact was 
raised among key personnel in the food and agriculture 
sectors. 
• Stakeholder and institutional technical capability in 
improving AMR surveillance, prevention, and control were 

















Engaging the food and 
agriculture sector in the 
target countries to 
promote the development 
and application of NAPs 
on AMR. Among the 
areas of focus were: 
advocacy and cross-
sectoral coordination for a 
One Health approach; 
reinforcing legislation on 
AMR; reducing antibiotic 
use through improved 
practices together with 
preventing the 
dissemination of resistant 
organisms across the food 
chain; and increasing 
national laboratory 
capacity in utilising data 
on the use of antibiotics, 
AMR and antibiotic 
residues. 
• Materials that promote awareness on AMR in appropriate 
antibiotic use, best production practices, governance, 
antibiotic registration, surveillance, and prevention of 
disease are expected to be generated. 
• The World Antibiotic Awareness Week is expected to 
promote awareness of One Health. 
• Updated communication tools on AMR that target food 
and agriculture sector stakeholders are expected to be 
generated. 
• An assessment of guidelines and regulations that are in 
existence, together with data on antibiotic use is expected. 







1.2.5.2 Selected OIE and WHO Initiatives from 2003 to date 
OIE is an organisation with an obligation to better animal health the world over. In curbing 
ABR, the OIE has been involved in capacity building and setting standards for Veterinary 
Services, veterinarians, para veterinarians, and other shareholders in animal production (OIE, 
2018). 
 
In a bid to avert and decrease ABR selection pressures caused by the use of veterinary 
antibiotics on bacteria, the OIE developed a list of antibiotics of veterinary importance. The list 
focuses on antibiotics used in food-producing animals and veterinary medicine. Following the 
Geneva and Oslo OIE/FAO/WHO Expert Workshops on Non-Human Antimicrobial Usage and 
Resistance held in 2003 and 2004, respectively, the OIE was requested to develop a list of 
critically important antibiotics for veterinary use. The WHO formulated a similar list for human 
medicine. The development of an OIE draft list was then deliberated upon by the member states 
in 2006 at the 74th General Session of the OIE International committee. After a series of 
meetings and reviews, the OIE came up with a list approved in May 2013. The list undergoes 
revision regularly. It underwent revision in 2015 and 2018 (OIE, 2019a). Veterinary antibiotics 
are categorised into veterinary critically important antimicrobial agents (VCIA), veterinary 
highly important antimicrobial agents (VHIA), and veterinary important antimicrobial agents 
(VIA). The classification is based on (1) > 50% of member states categorizing the antibiotic to 
be of veterinary importance based on a questionnaire and, (2) the availability of antibiotic 
alternatives for the management of serious disease conditions in animals. The antibiotic class 
was categorized based on whether it contained compounds considered extremely important in 
managing specific bacterial conditions coupled with a lack of alternative antibiotics that can be 
used as alternatives. Antibiotics meeting both benchmarks are categorised as VCIA while those 
that meet either of the two benchmarks are categorised as VHIA. Antibiotics meeting neither of 
the benchmarks are categorised as VIA (OIE, 2019a). Knowledge of the OIE list of important 
antibiotics for veterinary use (Table 1.3) among animal health professionals is necessary to 










Table 1.3: OIE list of antibiotics of veterinary importance (OIE, 2019a) 
Critically important 
antibiotics 






Quinolones (2nd generation)  
Ansamycin – rifamycins 


















The two OIE/FAO/WHO Expert Workshops on Non-Human Antimicrobial Usage and 
Resistance held in 2003 and 2004 led to the development of the “WHO CIA List” (OIE, 2019a). 
From the workshop in 2003, ABR was acknowledged as a concern in both animal and human  
health the world over. It was also recognised that ABR was influenced by antibiotic use in all 
sectors, and antibiotics used in therapy, disease prevention, and growth promotion in animals 
were similar to those available for human medicine. Conclusions that were drawn from the 
meeting include:  
• Resistant bacteria emerging from non-human antibiotic use had unfavourable 
consequences to human health in the form of high infection and treatment failure cases,  
• Non-human antibiotic usage patterns influence the development of antibiotic resistant 
bacteria in animals and food products and the ultimate dissemination to humans, and,  
• ABR effects were severe when bacteria resistant to antibiotics of critical importance to 
humans were involved (WHO, 2019). 
  
The WHO was then advised to appoint an expert clinical medical group to set down antibiotics 
regarded to be of critical importance to humans taking into consideration relevant bacteria that 
can potentially be disseminated to humans from food commodities, environment or animals 
(WHO, 2019). In 2005, the first list of critically important antibiotics was developed in 
Canberra, Australia, in the WHO Expert Meeting on Critically Important Antimicrobials for 
Human Health. The list has since undergone revision in 2007, 2009, 2011, 2013, and 2018 
(WHO, 2020). Antibiotic classes currently in use in human medicine are categorised as 
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critically important, highly important and important (Table 1.4), the basis for which is as 
follows: 
• The antibiotic class is the only one or is among the limited options available for the 
management of severe human bacterial infections, and,  
• The antibiotic class is used in the management of human infections due to bacteria that 
can be disseminated from non human sources to humans or bacteria attaining resistance 
genes from sources other than humans (WHO, 2019) .  
 
Antibiotics regarded as critically important meet both criteria, whereas those termed highly 
important meet either one of the criteria. Those antibiotics termed as important meet none of the 
two criteria. Critically important antibiotics are further categorised into highest priority and high 
priority antibiotics to help in allotting resources on antibiotics requiring urgent risk 
management. Three factors are considered in prioritising the critically important antibiotics. The 
first factor is associated with the people that might require the antibiotic for therapy, the second-
factor relates to the antibiotic’s frequency and intensity of use that increases the risk of ABR in 
the human population and the third-factor considers evidence of the dissemination of resistant 
bacteria or genetic elements of the resistant bacteria (WHO, 2019).  
 
CIAs that do not meet all the three factors fall under high priority CIAs (Table 1.4) (WHO, 














Table 1.4: WHO list of antibiotics of human importance (WHO, 2019). 
Critically important 
Highly important Important 
Highest Priority High Priority 
Glycopeptides 
Macrolides and ketolides 
Quinolones 
Polymyxins 









Phosphonic acid derivatives 
Penicillins (antipseudomonal, 
aminopenicillins and 
aminopenicillins with β-lactamase 
inhibitors) 
Lipopeptides 
Cephalosporins (1st and 2nd 








reductase inhibitors and 
combinations 
Pseudomonic acids 











Table 1.5: Critically important antibiotics of highest priority (WHO, 2019). 
Antibiotic Class Factors considered in prioritisation 
Cephalosporins (3rd and 
higher generation) 
• Select for cephalosporin- resistant E. coli and Salmonella spp. in animals 
• Are among the few therapies available for  managing severe E. coli and Salmonella spp infections in children. 
• The number of severe cases of E. coli and Salmonella spp infections is significant in humans. 
Macrolides and 
Ketolides 
• Select for macrolide-resistant Campylobacter spp. mainly Campylobacter jejuni in poultry.  
• Are among the few therapies available for managing severe Campylobacter infections in children. 
• The number of severe cases of Campylobacter spp infections mainly C. jejuni is significant in humans. 
Polymyxins (e.g., 
colistin) 
• Select for plasmid-mediated polymyxin resistant E. coli in animals 
• Intravenous polymyxins are among the few therapies available for managing severe multiresistant human infections caused 
by Pseudomonas aeruginosa and Enterobacterales, mainly in critical care. 
• The number of severe human cases due to Enterobacterales that may require colistin use is considered to be significant in 
humans. 
Quinolones • Select for quinolone-resistant E. coli and Salmonella spp. in animals  
• Are among the few therapies available for managing severe E. coli and Salmonella spp infections. 
• The number of severe cases of E. coli and Salmonella spp infections is significant in humans. 
Glycopeptides • Select for glycopeptide resistant Enterococcus spp. in animals 
• The use of avorpacin in growth promotion saw the development of vancomycin-resistant enterococci (VRE) in food animals, 
which were disseminated to humans. 
• Severe consequences occur as a result of a failure in treatment. 
• Are among the few therapies at hand in managing severe enterococcal infections. 
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Antibiotic use plays a role in the selection of resistant bacteria and the use of antibiotic agents in 
animal production acts as a driver for the emergence of resistant bacteria that can be 
disseminated to humans via the food chain. Reducing the use of antibiotics that are of critical 
importance to human medicine in animal production is crucial to maintain their benefits to the 
human population. Policymakers, veterinarians, and other animal health stakeholders can use 
the list in managing risks in food production (WHO, 2020).  
 
OIE supports quality veterinary education (undergraduate, postgraduate, and on the job training) 
to promote the health and welfare of animals, human beings, and the environment. Upon noting 
some deficiencies in veterinary education in most of its member states, the “Veterinary 
Education Core Curriculum OIE Guidelines” was published in 2013 (OIE, 2012; OIE, 2020a). 
The guidelines are to be used by veterinary institutions in the development of curricula to assure 
required competency levels for graduating veterinary students in member states. Veterinary 
institutions may adapt the guidelines to suit their educational requirements. As part of the 
Veterinary Microbiology course, students have to be taught : (1) bacterial characteristics, 
classification, isolation, and identification (2) pathogenesis of bacterial infections, (3) clinical 
signs, available clinical and laboratory tests for diagnosis (4) treatment modalities, (5) ABR 
development, (6) appropriate antibiotic use and, (7) infection prevention and control (OIE, 
2013). Such knowledge, combined with the right attitude, will inform the best practices which 
prevent ABR emergence and spread. 
 
Following the development of the GAP on AMR by the tripartite alliance of the WHO, OIE, 
and FAO, the OIE’s General Assembly took up Resolution 36 that instructs the OIE to organise 
its AMR projects into a strategy in 2016. In November 2016, “The OIE strategy on 
Antimicrobial Resistance and the Prudent Use of Antimicrobials” was published. The OIE’s 
strategy is in line with the GAP and acknowledges the need for a One Health approach in 
curbing ABR. It provides the OIE’s strategies and goals and encourages member states to take  
ownership and undertake implementation at national level. The strategy contains four objectives 
which are to:   
• “Improve the level of awareness and understanding;  
• Reinforce knowledge via research and surveillance;  
• Support good governance and capacity building and, 
• Encourage the implementation of international standards” (OIE, 2016). 
 
Objective 1 is the focus of this study and is thus discussed in detail here. 
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Objective 1: To improve the level of awareness and understanding among animal health 
professionals  
To achieve this objective, the OIE seeks to assist member states by developing materials 
targeted at animal health professionals that promote an understanding of AMR and its 
associated risks. The OIE will also support efforts that decrease antibiotic use and the 
occurrence and dissemination of antibiotic resistant bacteria in animals. AMR awareness will 
also be promoted through veterinary education establishments and statutory bodies. Support in 
organising and conducting symposia, conferences, and workshops that address AMR and 
appropriate antibiotic use will be rendered. The OIE will also increase its scientific, guidance, 
and educational material linked to curb the occurrence and dissemination of antibiotic resistant 
bacteria while encouraging proper husbandry techniques, vaccination programmes, and good 
biosecurity to avert diseases and the need for antibiotics. OIE will also join forces with the FAO 
and WHO in policy coordination and alignment on AMR (OIE, 2016). 
 
Concerning improving the level of awareness and understanding among animal health 
professionals, the OIE has produced standards that are constantly improved and issued in the 
form of the “Terrestrial Animal Health Code” and the “Aquatic Animal Health Code” among 
others. The standards lay out methodologies for member states to effectively prevent the risk of 
occurrence and dissemination of antibiotic resistant bacteria due to antibiotic usage in animal 
production (OIE, 2020b). The “Terrestrial Animal Health Code” provides information on 
appropriate antibiotic use in veterinary medicine. The veterinarians are expected to contribute to 
animal health and welfare and public health through proper practices. A thorough clinical 
examination of the animal should be done before administering and prescribing antibiotics. The 
OIE list of antimicrobial agents of veterinary importance should be followed when prescribing 
and administering antibiotics. Clinical experience and laboratory testing should justify the 
choice of an antibiotic in the treatment of a disease. Following the failure of first-line antibiotic 
treatment or in the event of disease recurrence, diagnostic testing should justify second-line 
antibiotic treatment. However, a different antibiotic class or subclass can be used if diagnostic 
tests are unavailable. It is also expected that the use of antibiotic combinations is not 
recommended unless justified . Veterinary schools, research institutes, and professional bodies 
are advised to offer training on antibiotic usage aimed at preserving antibiotic efficacy (OIE, 
2019b).  
 
The “Aquatic Animal Health Code” lays out guidelines on appropriate antibiotic use in aquatic 
animals. A rigorous clinical assessment should precede antibiotic usage in aquatic species. The 
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veterinarian or any other authorised aquatic animal health professional should utilise a clinical 
examination, post-mortem examination, bacteriology with culture and sensitivity where possible 
in order to reach a definitive diagnosis. Poor water quality and other environmental factors are 
considered sources of infection; therefore, they must be assessed and improved accordingly 
before antibiotic usage in aquatic species. The standard also recommends training veterinarians, 
and other aquatic animal health professionals on appropriate antibiotic use by veterinary 
schools, research institutes and professional bodies (OIE, 2019c). Knowledge of appropriate 
antibiotic use among animal health professionals will inform good practices, thereby preserving 
antibiotic efficacy. Such will have a positive impact on animal welfare and public health. 
 
In 2018, the second OIE global conference on AMR and prudent use of antimicrobial agents 
was held in Marrakesh, Morrocco. It aimed to increase the level of understanding of AMR in 
animals among professionals, experts, international organisations, donors, policymakers, and 
OIE delegates. It was also a platform to identify effective ways to assist member states in 
fulfilling the AMR OIE strategy and the GAP objectives. One of the conference's focus areas 
was to deliberate on communication materials and strategies leading to behavioural changes in 
antibiotic use in veterinary medicine (OIE, 2018). It was reported that the OIE, together with the 
FAO and the WHO, celebrate the World Antibiotic Awareness Week annually. The OIE has 
also developed communication campaigns that assist national veterinary services in member 
states with guidelines on developing NAPs. Information resources are also available on the OIE 
website for veterinarians and other stakeholders as a strategy to improve AMR awareness 
(Bertrand-Ferrandis and Gabourie, 2018). The need for communication is based on the principle 
that the information that humans access determines their behaviour. From this reasoning, the 
importance of communication as a tool for influencing antibiotic use behaviour was born.  
 
Communication has been used the world over as a tool for raising awareness. Using a One 
Health approach and being led by the Department of Veterinary Services (DVS), experts across 
the agriculture, health, and academic sectors and non-governmental organisations in Kenya 
developed a communication strategy on AMR in 2017. The strategy was a course of action on 
the prevention and containment of AMR in the country. Through education, training, and 
effective communication, the strategy was meant to enhance AMR awareness and understanding 
(Njagi, Azegele and Othieno, 2018). It was also reported that the OIE held a set of regional 
seminars that consisted of behavioural change exercises to reinforce Veterinary Services’ 
capacity on risk communication and behavioural change. The behavioural change initiatives 
were meant to establish timelines, outputs, barriers, and interventions for desired behaviours in 
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veterinarians, farmers, retailers, consumers, and policymakers. Although the lack of funding and 
inadequate legislation were identified as common barriers in sustaining the efficacy of 
antibiotics, there was overwhelming support for strategies that raise awareness on AMR 
amongst the stakeholders mentioned above (Bertrand-Ferrandis and Gabourie, 2018). Effective 
communication in education and training on ABR will improve knowledge, thus informing the 
attitudes and practices of animal health professionals on antibiotic use. 
1.2.5.3 Selected containment strategies in South Africa 
Various professional bodies and national departments have been involved in the fight against 
the global ABR problem by promoting appropriate antibiotic use practices. Collaboration in the 
form of a One Health approach is necessary for effective ABR containment. 
 
To complement efforts made by the WHO, FAO and OIE to contain ABR from a One Health 
perspective, the National Department of Health and the then Department of Agriculture, 
Forestry, and Fisheries (DAFF) developed the National Antimicrobial Resistance Strategy 
Framework, covering 2018 to 2024. The strategic framework seeks to ameliorate antibiotic use 
in both the animal and human health sectors to minimise ABR dissemination across the food 
chain. Its strategic objectives include: 
(1) Strengthening, coordinating and institutionalising interdisciplinary and intersectoral efforts 
by way of governing structures that involve health experts in animal, environmental and 
medical sectors,  
(2) Diagnostic stewardship to refine diagnostic testing, pathogen identification and treatment, 
(3) Optimising ABR and antibiotic use surveillance, 
(4) Enhancing biosecurity, prevention and control of infections to curb ABR dissemination, 
and, 
(5) Promoting appropriate antibiotic use by way of awareness campaigns on ABR and 
appropriate antibiotic use, species-specific guidelines for appropriate antibiotic use, 
antibiotic stewardship programmes and governed antibiotic access.  
 
Educating the animal health profession on antibiotic stewardship, pharmacology, infection 
prevention and control and microbiology is expected to promote the execution of the strategic 
objectives. Strategies that effectively improve ABR containment will be integrated into the 
animal health profession curricula at both the undergraduate and postgraduate levels. KAP 
studies on antibiotic use and ABR are also expected to provide an evidence base that allows 
effective execution of the strategic objectives (DoH, 2018). 
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The South African Veterinary Association (SAVA) is an association representing member 
interests. The association's membership consists of veterinarians and para-veterinarians. SAVA 
is also responsible for promoting veterinary science and the veterinary profession (SAVA, 
2015). In 2002, the Medicines Committee of the South African Veterinary Association 
coordinated with the Faculty of Veterinary Science, University of Pretoria, and produced 
national guidelines on appropriate antibiotic use in veterinary medicine. The guidelines were 
intended to encourage safe and effective antibiotic use that reduces selection for antibiotic 
resistant bacteria in animals while maintaining antibiotic efficacy. Such an initiative would 
prevent the dissemination of resistant bacteria in animals hence maintaining animal health. It 
would also protect consumers' health as they would consume food of animal origin with high 
standards of safety. Dissemination of resistant bacteria or resistance genes from animals to 
human beings would also be minimised thereby maintaining efficacy of antibiotics intended for 
human health. The guidelines emphasized the need for veterinary institutions, research 
institutes, and professional bodies to educate and train veterinarians to foster knowledge on 
ABR and appropriate antibiotic use. The programmes should include: (1) the potential of 
antibiotics to select antibiotic resistant bacteria in animal production causing problems in animal 
health and human health, (2) strategies in disease prevention and management in order to 
minimise antibiotic use, (3) the relevance of bacteriology and susceptibility testing in the 
process of diagnosis, (4) appropriate information on pharmacokinetics and pharmacodynamics, 
and (5) the importance of administering antibiotics in livestock farming following the marketing 
authorisation and or veterinary prescription requirements (SAVA, 2002). Over the years, SAVA 
has also been involved in providing continuing professional education (CPD) for its members 
on antibiotics and ABR. 
 
The South African Veterinary Council (SAVC) regulates the veterinary and para-veterinary 
professions in the country. Among its responsibilities is to ensure that the professions 
mentioned above are well informed and, hence, incorporate the One Health plan in their 
curricula. It also ensures ongoing education on antibiotic prescribing and dispensing for their 
members. The SAVC is linked together with other national organisations in the human health 
and environmental sector to effectively control ABR through the Antimicrobial Resistance 
National Strategy Framework (Van Vuuren, 2016). The discovery of plasmid-mediated gene 
mcr-1 conferring mobilized resistance to colistin an antibiotic of last resort in human beings in 
2016, resulted in the SAVC instruction to registered veterinarians and para-veterinarians not to 
use colistin in food-producing animals unless results from culture and sensitivity justify its 
usage. Failure to comply is deemed unprofessional conduct (Registrar of Medicines, 2016). 
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Colistin is currently ranked among the critically important antibiotics of the highest priority on 
the WHO CIA list. Thus, it should be preserved for human health (WHO, 2019).  
 
The state veterinary services in the then DAFF introduced the South African Veterinary 
Strategy 2016-2026. The strategy forms the foundation on which the South African government 
fulfils its responsibilities and commitment to providing safe and sufficient food of animal origin 
to its citizens. The strategy aims to encourage animal and human well-being by creating 
mechanisms and systems to deliver efficient state veterinary services involved in effective 
prevention, detection, containment and the elimination of public and animal health risks. The 
Veterinary strategy recognises the need for an integrated antimicrobial resistance programme 
between DAFF and the Department of Health. The OIE and WHO programmes that are in 
existence are to be used as guides. The following areas address antimicrobial resistance: 
• “Clear definition and scope of antimicrobials;  
• Use and distribution of veterinary medicines and other antimicrobials; 
• Traceability on the use of antimicrobials; 
• Surveillance on antimicrobial resistance; 
• Use of biosecurity and management practices to limit the use of antimicrobials; 
• Prohibition of the use of compounded medicine in food-producing animals; 
• Restrict antimicrobial use to therapeutic use only and not prophylactic use; 
• Advise end-users on appropriate use of antimicrobials at points of sale; 
• Veterinary inspection of cooperatives; 
• Accountability of pharmacists for the drugs they dispense; 
• Reconsideration of direct sale of pharmaceuticals to farmers by pharmaceutical 
companies and, 
• Compulsory drug registers” (DAFF, 2016)  
 
Antimicrobials can be purchased over the counter as stock remedies or farm feeds. They are 
regulated by the Fertilizers, Farm Feeds, Agricultural Remedies, and Stock Remedies Act (Act 
36/1947) that enables direct farmer access to stock remedies for tick-borne diseases and animal 
husbandry practices, for example, in cases where veterinarian access was impossible (Eager and 
Naidoo, 2017). However, from the draft regulations that were published for comment by Act 
36/1947 in 2020, the stock remedies are re-classified in such a way that certain antibiotics fall 
under Group A for access and use by veterinarians only as registered in terms of the Veterinary 
and Para-veterinary Professions Act 19 of 1982 (Department of Agriculture, Land Reform and 




The South African Animal Health Association (SAAHA) has also been involved in the 
containment of ABR. The association provides a service to farmers and other veterinary product 
end-users. It seeks to support and promote an animal health industry that is innovation-driven 
and viable, thus contributing to a safe, secure, and healthy food supply via a high level of health 
and welfare of all animals and the environment (SAAHA, 2020). After various bodies mounted 
pressure for over the counter antibiotic stock remedies to be regulated as scheduled veterinary 
medicines in Act 101/1965, SAAHA has been involved in a proposal to the Department of 
Health to motivate for the continued availability of over the counter antimicrobials to farmers to 
avert adverse outcomes on animal health and welfare. SAAHA drafted a proposal that supported 
the antibiotics to remain with Act 36/1947 but with greater control over their sales to encourage 
antibiotic stewardship. The proposal submitted to the Department of Health included: 
1. Sales staff wishing to recommend and or dispense antibiotics must be trained on 
appropriate antibiotic use through a monitored and approved course,  
2. Antibiotic sales are to be recorded by the dispenser,  
3. A responsible Veterinarian must be available in all intensive operations and is 
responsible for all medicaments used, including appropriate antibiotic use, and 
4. Antibiotics are to be classified based on criteria that will determine their use. Such 
criteria include free use to no use in veterinary medicine if the antibiotic is only 
registered for use in humans (Eager and Naidoo, 2017).  
 
Following an OIE appeal to member countries to carry out efforts to set up national programmes 
for antimicrobial resistance management, the South African National Veterinary Surveillance 
and Monitoring Programme (SANVAD) for Resistance to Antimicrobial Drugs was created in 
2003 in response . to the international standards established by the OIE in May 2002 for animal 
bacteria antimicrobial resistance detection and quantification. Participating laboratories were set 
up, and training was provided to the laboratory technologists to utilise the newly published 
methodologies in the OIE International Standards on Antimicrobial Resistance towards 
developing and standardizing  a surveillance and monitoring program. Following the OIE 
guidelines, the South African surveillance and monitoring programme was based on pathogenic 
animal bacteria, zoonotic bacteria, and indicator bacteria. Such basis enabled data production on 
public health risks and problem identification due to decreased antimicrobial drug efficacy. The 
VetMic system was used to determine the minimum inhibitory concentrations. According to the 
2007 SANVAD report, from the 430 E. coli isolates tested, it was observed that 288 (67%) of 
the isolates were resistant to at least one antibiotic  effective against E. coli. Resistance was 
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highest to sulphonamides and tetracyclines and lowest to ceftiofur. Poultry E. coli isolates were 
more resistant than those from other animal species. It was also observed that isolates collected 
from healthy chickens’ intestinal tracts from abattoirs recorded higher resistance compared to 
those from sick birds. Among the zoonotic pathogens, a total of ten isolates of Salmonella 
enterica from pigs were all resistant to sulphonamides, tetracyclines, and chloramphenicol. 
Among the pathogenic bacteria, ten isolates of Mannheimia haemolytica were obtained from 
cattle. Although resistance was low generally, resistance was high for tetracyclines neomycin 
and erythromycin (Van Vuuren, Picard and Greyling, 2007). The national surveillance 
programme was discontinued and is yet to be re-introduced in animal health (DoH, 2018). 
The South Africa Antimicrobial Stewardship Programme (SAASP) has veterinary 
representation. The aims and values of SAASP include to: 
• “Provide leadership, advocacy for, and strengthening of, antibiotic stewardship in the 
public and private sectors of human and animal health in South Africa; 
• Direct appropriate training in antibiotic stewardship in all sectors of human and animal 
health care; and, 
• Identify gaps in current knowledge and the necessary operational research/audit that 
will inform practice. Provide feedback on the results of these studies to stakeholders, so 
as to implement change” (Eager and Naidoo, 2017). 
 
In 2015, the South African Health Products Regulatory Authority, formally known as the 
Medicines Control Council, implemented a guideline for antibiotic intramammaries. The 
guideline required applicants to undertake minimum inhibitory concentration (MIC) tests from 
local mastitic cultures in South Africa as a requirement to register their intramammaries in order 
to inform and act accordingly on any ABR trends picked up from these local laboratory tests 
(MCC, 2013). 
 
1.2.6 Knowledge, attitudes, and practices studies on ABR 
Knowledge, attitudes, and practices (KAP) studies have contributed to knowledge on ABR. 
Gaps identified can help mitigate antibiotic resistance. Studies below illustrate some of the 
common findings identified the world over. 
1.2.6.1 Developed countries 
In 2014, a questionnaire-based study was conducted to evaluate behaviours in antibiotic 
prescribing, attitudes to ABR, and perceptions of appropriate antibiotic use in pigs among 
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veterinarians with a clinical caseload of commercial pigs in Scotland, Wales, and England. The 
questionnaire comprised open and closed questions and statements on a 5 point Likert scale 
evaluating prescribing behaviour, ABR perceptions, and what was perceived as appropriate 
antibiotic use behaviour. The questionnaire was piloted among veterinarians on a farm animal 
practice in one of the UK’s universities. Through the use of the Royal College of Veterinary 
Surgeons (RCVS) veterinary practise database of 2014, the questionnaire was then distributed 
via an online mailing list to veterinarians with a clinical caseload of commercial pigs. A paper-
based copy was made available to respondents who did not make use of the online platform. 
From a total of 179 responses, only 61 were usable. A majority of the respondents (≈ 93%) were 
of the view that the decision on antibiotic prescribing was favoured by the desire to ensure 
animal welfare, and having confidence in the diagnosis of the type of bacteria causing the 
infection. Antibiotic use in pigs was considered to have an effect on antibiotic resistance in pigs 
by 67% of the respondents. Conversely, only 45% of the veterinarians believed antibiotic use in 
pigs has an effect on antibiotic resistance in humans. It was also observed that antibiotic 
susceptibility testing was more common with treatment failure (≈20% of the respondents) 
compared to the initial treatment stages when bacteria was first suspected (≈43% of the 
respondents). A poor response to treatment was attributed to ABR by less than 10% of the 
respondents. Antibiotic use behaviours that were regarded as exemplifying appropriate 
antibiotic use in pigs were assessed for colistin (Coyne et al., 2018). Colistin is an antibiotic of 
last resort in humans that has shown to be effective in managing multidrug- resistant P. 
aeruginosa (Hachem et al., 2007), Enterobacterales resistant to carbapenems (Gales, Jones and 
Sader, 2011) and Acinetobacter baumannii resistant to carbapenems (Gordon and Warcham, 
2010). Colistin use in pigs was perceived as being usually justified by 49% of the respondents. 
Most respondents (72%) were of the opinion that therapeutic antibiotic use was always justified, 
whilst only 5% shared the same opinion for prophylactic antibiotic use. Most respondents 
believed that the veterinarian (>70 %) and the farmer (>40%) are very crucial in monitoring the 
appropriate  use of antibiotics, fewer respondents(< 30%) shared the same sentiments for the 
European Union, UK government, retailers and farm assurance schemes. It was concluded that a 
One Health approach is necessary in mitigating antibiotic resistance (Coyne et al., 2018).  
In a bid to assess the knowledge, attitudes, and practices on antibiotics and resistance, a cross-
sectional multicentre study was carried out among 255 students in 25 universities from the UK 
in 2016. The study comprised 25 questions with sections assessing knowledge, attitudes, and 
practices concerning antibiotics, ABR, and antibiotic stewardship awareness. Students received 
an invitation to participate in the study via email before the survey was made available online. 
From a sample of 71 students from veterinary medicine, students were assessed whether (1) 
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bacteria and, (2) animals could become resistant to antibiotics. All students agreed that bacteria 
could become resistant to antibiotics. Only 34% agreed that animals could become resistant to 
antibiotics. About 11 % of the students suggested the need for more information on how to use 
antibiotics, while 47% needed more information on antibiotic resistance, 27% on antibiotic 
prescribing and 69% on the link between human, animal and environmental health. 
Approximately 67 % of the students had heard about the British Veterinary Association’s 
(BVA) seven point plan that was intended to encourage appropriate antibiotic use in veterinary 
medicine. It was then concluded that veterinary medicine students in the UK had adequate 
knowledge of ABR. The misconception on animals becoming resistant to antibiotics could be 
addressed by more education (Dyar et al., 2018).  
In 2015, a cross-sectional study was done in Germany to assess the perceptions and attitudes on 
ABR of veterinarians, pig farmers, general practitioners, hospital physicians, and the general 
public. Of the 60 veterinary surgeons, 53% perceived their use of antibiotics influenced the 
occurrence of ABR. Only 40% of the veterinarians considered ABR as important in their daily 
work. Veterinarians chose three topics on ABR mitigation related to the human sector rather 
than those in their area of function. Scientific journals (83.3%) and clinical practice guidelines 
(81.7%) were selected by most veterinarians as important sources of information on antibiotic 
use. About 67% of veterinarians were in the habit of discussing ABR with their clients in both 
instances of prescribing and not prescribing antibiotics. It was concluded that a One Health 
approach is necessary in the development of educational materials for veterinarians to take 
ownership in mitigating ABR (Schneider et al., 2018).  
In 2007, a questionnaire-based study was conducted in Ohio, America, to determine the 
knowledge, beliefs and practices concerning ABR amongst veterinarians on dairy farms. The 
questionnaire comprised 26 questions on a five point Likert scale, assessing knowledge, beliefs, 
and practices. A pilot study of the survey was done on four bovine veterinarians prior to survey 
dissemination. Forty-three out of 168 bovine veterinarians responded to the survey. It was 
observed that the number of respondents who agreed to ABR affecting animal health negatively 
(86%) was more than those who agreed to ABR affecting human health negatively (63%). A 
decrease in antibiotic effectiveness was observed by 37% of the respondents. More than 80% of 
the respondents were comfortable in responding to questions pertaining to ABR. However, only 
a minority of them (23%) would regularly initiate ABR discussions with clients. A few 
respondents (23%) were involved in providing protocols for antibiotic use to the dairy 
producers. One-on-one meetings were chosen by more than 75% of the respondents as the most 
effective way to raise awareness on ABR to producers. It was concluded that efforts should be 
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made to encourage the flow of information between bovine veterinarians and their clients to 
effect the appropriate use of antibiotics (Cattaneo et al., 2009). 
1.2.6.2 Developing countries 
In order to assess the knowledge, attitudes, and awareness of AMR, an online cross-sectional 
survey was carried out in Nigeria among veterinary undergraduates (excluding 1st -year 
students) in 10 of the 12 veterinary schools in 2018. The survey consisted of questions assessing 
knowledge, attitudes, and awareness on the use of antibiotics and AMR in animals and human 
beings. From 426 respondents, it was found that AMR knowledge scores were low for 60% of 
them. About 33.2% of the respondents also recorded low scores on factors contributing to 
AMR. Students attending clinical years were more knowledgeable about the use of antibiotics 
and factors contributing to AMR than the other students. AMR control recorded attitudes that 
were impressively positive; most respondents asserted that antibiotics dispensing over the 
counter or without prescription should be controlled (90%). Most respondents also asserted that 
antibiotic prescribing should be controlled closely (91%). This was also true for poor infection 
control practices as a cause of AMR spread (81%). Conversely, a smaller percentage of the 
respondents (47.4%) admitted to having adequate knowledge of antibiotic prescription. 
Additional  education and training on AMR to students in clinical years was regarded as a 
necessity by more than 87% of the respondents. The level of awareness on common AMR terms 
was low, few of the respondents were familiar with the terms “superbugs” (82.9%), 
“antimicrobial stewardship” (86.9%), “Global Action plan on AMR” (81.9) and “National 
Action Plan for AMR, Nigeria” (72.5%). It was concluded that veterinary schools should focus 
on gaps in knowledge, attitudes, and awareness of the global problem of AMR (Odetokun et al., 
2019). 
A qualitative study was done in the Indian state of Orissa to explore opinions on antibiotic use 
and resistance development in connection with the environment among registered veterinarians. 
Using face to face semi-structured interviews, two themes were observed, (1) an 
interrelationship between antibiotic use, ABR development, and the environment and (2) 
antibiotic management contributing to the development and dissemination of resistance. Under 
the first theme, the respondents believed the climate had an influence on antibiotic prescribing. 
Each season had its disease challenges, which prompted antibiotics to be prescribed. Poor 
disposal of antibiotics was also thought to contaminate the environment, thereby aiding in the 
development of antibiotic resistance in bacteria that are disseminated by water. However, some 
of the respondents believed further scientific investigation was necessary to investigate the link 
between ABR and the environment. Under the second theme, the veterinarians reported that 
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antibiotics that were commonly in use for humans were also frequently used in poultry and 
dairy, with some of them being used in growth promotion, and suggested that such use in 
animals was contributing to ABR in humans. The unavailability of trained personnel and 
reliable laboratories to carry out susceptibility testing was seen as the reason behind 
inappropriate antibiotic use in the veterinary sector. It was concluded that environmental 
changes, human behaviour, and interaction with the environment have an impact on ABR 
development. Further education, and, implementing, and enforcing proper drug policies were 
necessary to promote the proper use of antibiotics and prevent environmental contamination 
with antibiotics (Sahoo et al., 2010). 
In order to determine AMR awareness and knowledge on antibiotics, qualitative studies were 
carried out between April and November 2017 in Nigeria and India. Semi-structured interviews 
were carried out among veterinarians involved in prescribing and dispensing antibiotics. The 
respondents reported that a lack of proper biosecurity measures, proper nutrition, and poor 
hygiene led to antibiotic prescribing and dispensing, which encouraged the development and 
dissemination of ABR. Respondents also felt that antibiotic prescribing was also done to avoid 
unfavourable outcomes, conflicts and legal battles with clients. Difficulties in enforcing drug 
withdrawal periods due to challenges with economic compensation for the farmer were also 
reported. Thus, striking a balance between maintaining antibiotic efficacy and reducing the 
presence of antibiotic residues in animal protein whilst sustaining livelihoods was somewhat 
difficult. The use of probiotics and vaccines as opposed to antibiotics in disease prevention was 
suggested to curb ABR. The results show that awareness of ABR was high. However, issues 
such as the lack of farmer compensation, poor adherence to antibiotic withdrawal periods, and 
avoiding legal battles with clients would prompt deviation from good practice (Pearson et al., 
2018).  
1.2.6.3 South African studies 
A survey was carried out in South Africa to set a point of reference for surveillance and 
monitoring of antibiotic volumes available for use in food animals. The data generated would 
assist in the appropriate use of antibiotics, thus preserving their efficacy. Data on antibiotic 
volumes used and supplied in South Africa between 2002 and 2004 was collected and presented 
as kg of active ingredient from approximately 32% of the veterinary pharmaceutical companies. 
Information on antibiotics approved for veterinary use was collected through applications that 
were done under two Acts controlling antibiotic availability in South Africa (Act 36 of 1947 
representing over-the-counter Stock Remedies and Act 101 of 1965 representing drugs in which 
a veterinary prescription is necessary under the Medicines and Related Sustances Control Act). 
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A calculation was made for the volume of sold in-feed antibiotics from data supplied by the 
companies. Two hundred and thirty-four registered antibiotics were accessible for food animal 
use. Most of these (72%) were registered through Act 36 of 1947, and 28% were registered 
through Act 101 of 1965. An average of 1 538 443kg of active ingredient was sold between 
2002 and 2004. Macrolides and pleuromutilins (42.4%), tetracyclines (16.7%), sulphonamides 
(12.4%), and penicillins (10.7%) were the commonly used antibiotics. Most antibiotics were 
administered in-feed (69%) and via the parenteral route (17.5%). Macrolides, lincosamides, and 
pleuromutilins were the most common in-feed antibiotic classes (61.6%), and glycolipids were 
the least (0.4%). Penicillins were the most common antibiotic class given via the parenteral 
route (60%), and aminoglycosides were the least (0.1%). It was concluded that data on 
antibiotic consumption should be paired with ABR surveillance and monitoring to curb ABR 
and its associated problems effectively (Eagar, Swan and Van Vuuren, 2012). 
 
A quantitative questionnaire-based study was done in 2014 to determine the level of knowledge 
and perceptions towards ABR among the University of Pretoria pre-final and final year 
veterinary students. From the 71 questionnaires that were analysed,  all the students considered 
ABR as a global threat to both humans and animals. Most of the students agreed that antibiotic 
misuse by veterinarians (84.5%) and farmers (98.6%) contributes significantly to ABR. Most of 
the students were confident in their knowledge of antibiogram interpretation (62.9%) and 
identifying the most appropriate route of administration for an antibiotic (58.6%). However, low 
confidence was observed in knowledge on the side effects, indications and contraindications of 
antibiotic classes frequently used by veterinarians (17.1%), mechanism of antibiotic resistance 
(32.9%), choosing an alternative antibiotic secondary to failure in initial treatment (30%) and 
identifying the appropriate duration in antibiotic therapy (37.1%). The study pointed out 
knowledge gaps in antibiotic therapy, which can be used when formulating veterinary curricula 
(Smith et al., 2019). 
In 2014, a multi-country survey was done among veterinary students from eight veterinary 
institutions from South Africa, Sudan, and Nigeria to investigate knowledge, attitudes, and 
perceptions on antimicrobial use. A semi-quantitative questionnaire was used, and pre-final and 
final year students participated in the survey. From 353 responses that were received, 71 
(20.1%) were from South Africa, while 105 (29.7%) were from Nigeria and 177 (50.1%) were 
from Sudan. Overall, perceptions of antimicrobial stewardship were poor among students. Only 
174 (50.7%) of all the respondents agreed to AMR as an increasing global threat to human and 
animal health. One hundred percent of students from South Africa agreed to the statement 
compared to 101 (98.1%) and 3 (1.8%) from Nigeria and Sudan, respectively. Only 156 (45.9%) 
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of all the respondents agreed that providing lay people with education on the importance of 
antimicrobials as controlled scheduled substances will positively impact decreasing AMR rise. 
Sixty-two (87.3%) of the students from South Africa were in agreement compared to 85 
(84.2%) and 10 (5.8%) of the students in Nigeria and Sudan, respectively. Only 172 (50.1%) of 
all the respondents agreed that antimicrobial misuse by veterinarians may significantly 
contribute to AMR. Sixty (84.5%) of the students from South Africa were in agreement 
compared to 92 (89.3%) and 22 (12.6%) of the students in Nigeria and Sudan, respectively. 
Only 154 (44.9%) of all the respondents agreed that undergraduate training had prepared them 
well enough to make informed choices on selecting the ideal antimicrobial for an animal. Fifty-
four (76.1%) of the students from South Africa were in agreement compared to 92 (90.2%) and 
8 (4.6%) of the students in Nigeria and Sudan, respectively. Significantly high correct responses 
(p<0.05) were recorded in half of the questions on perceptions in the pre-final students than 
those in the final year. Generally, confidence was recorded among students on knowledge of 
antimicrobials. Most respondents were confident in making a Gram stain 225 (69.2%), choosing 
an ideal route for administering a specific antimicrobial 248 (74.7%) and resistance mechanisms 
223 (68%). Students from South Africa were the least confident in all the three scenarios, which 
were 40 (56.3%), 42 (59.2%) and 23 (32.9%) respectively compared to students from Nigeria 
and Sudan who were 85 (87.6%) and 101 (62.7%); 73 (76%) and 135 (79.9%); 68 (71.6%) and 
135 (80.8%) respectively. Overall, few of the respondents were confident in differentiating 
time-dependent from concentration-dependent antimicrobials 159 (48.1%) with students from 
South Africa 47 (66.2%) being more confident than those from Nigeria 30 (30.9%) and Sudan 
84 (50.3%). In decreasing order, students perceived the abuse of veterinary antibiotics in the 
following order: tetracyclines, penicillins, sulphonamides, macrolides, aminoglycosides, 
quinolones, amphenicols, polypeptides, cephalosporins, antimicrobial combinations, and others. 
It was concluded that identified knowledge gaps in antibiotic stewardship need to be addressed 
in the curricula of veterinary students (Fasina et al., 2020). 
 
In 2014, antibiotic usage patterns of small animal veterinarians were investigated in South 
Africa. Compliance with appropriate antibiotic use practices was evaluated through a cross-
sectional online survey. A population of 1120 veterinarians registered with the SAVC in 2014 
was targeted. Of the 181 veterinarians who responded to the survey, a few had practice set 
protocols for antibiotic treatment 48 (26.52%). Empirical antibiotic use was common among 
respondents before testing in the laboratory 165 (91.16%). Most respondents encountered a 
return of patients due to poor antibiotic efficacy 174 (96.14%). The off label use of human 
registered antibiotics was common in 156 (86.19%) by respondents. Susceptibility records from 
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canine samples submitted for culture and susceptibility testing at the Faculty of Veterinary 
Science, bacteriology laboratory between 2007 and 2013 were also analysed. The standard 
Kirby Bauer method was used in determining susceptibility to antibiotics, and resistance 
prevalence was computed as the number of resistant bacterial isolates as a percentage of the sum 
of isolates. E. coli and Staphylococci were the most commonly isolated bacteria. Resistance to 
the frequently used antibiotics for Staphylococci was 71.62% for penicillin G, 78.50% for 
amoxicillin/ampicillin, 18.63% for tylosin, and 19.96% for amikacin. For E. coli, resistance was 
96.81% for penicillin G, 69.86% for amoxicillin/ampicillin, 93.04% for tylosin, and 34.20% for 
amikacin. For all isolates, multi-drug resistance (resistance to one or more antibiotics from three 
or more distinct antibiotic classes) was more than 50%. The study demonstrated the presence of 
resistant bacteria in small animal practice together with poor implementation of appropriate 
antibiotic usage guidelines. Treatment guidelines should be incorporated in the veterinary 
curriculum for undergraduates and in CPD courses for veterinary professionals to curb ABR 
development and spread (Chipangura et al., 2017). 
These studies unlock vital information, which, through careful consideration, might assist in 
mitigating ABR. Therefore, it is necessary to assess the knowledge, attitudes, practices and 
experiences of animal health professions in the South African veterinary sector. Results from 
other studies combined with local results from our study will improve ABR containment 
strategies that fit the local South African setting. The fight against ABR involves many sectors 
including the veterinary sector hence the need for an integrated approach. 
1.3 METHODOLOGY 
1.3.1 Ethical Consideration 
Ethical approval was obtained from the Biomedical Research Ethics Committee of the 
University of Kwa-Zulu Natal (Reference No.: BE033/19) (Appendix 1). Informed voluntary 
consent was obtained from all the participants in the preamble to the questionnaire. 
1.3.2 Aim 
The aim of the study was to determine the knowledge, attitudes and practices of 
veterinary/animal health professions on antibiotic use, antibiotic resistance (ABR), and its 
containment in the South African veterinary sector.  
1.3.3 Objectives 
1. To design a questionnaire using examples of similar studies from the literature. 
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2. To pilot this questionnaire among veterinarians who did not form part of the final 
sample population. 
3. To identify and obtain gatekeeper permission from the professional associations whose 
members will be potential participants. 
4. To run the online questionnaire survey amongst members of the participating 
associations. 
5. To consolidate the raw data in a manner that facilitates statistical analysis. 
6. To correlate socio-demographic data with relevant knowledge attitude and practices 
parameters using appropriate statistical methods. 
7. To make recommendations for interventions based on the results  
1.3.4 Study Design 
This was a quantitative, descriptive study. 
1.3.4.1 Setting: The study was conducted within South Africa, nationally. 
1.3.4.2 Participants:  
The population comprised of: 
All veterinarians, veterinary nurses, animal health technicians, and veterinary technologists who 
were members of SAVA and South African Association for Laboratory Animal Science 
(SAALAS).  
Sample Size:  





1.3.4.3 Data Collection Tool: 
Data was collected using an online self-administered questionnaire (supplementary material). 
The questionnaire was adapted from four questionnaires used in previous similar studies 
(University of Colorado Denver, 2018; Hardefeldt et al, 2018; Sadiq et al, 2018; Ekakoro and 
Okafor, 2019). The questionnaire was divided into four sections consisting of closed-ended 
questions (yes or no) and Likert style (strongly agree/agree/neutral/disagree/strongly disagree) 
questions. Section 1 focused on the socio-demographic characteristics of participants and 
sections 2-4 dealt with knowledge, attitudes, and practices of participants on antibiotic use, 
ABR, and its containment in the South African veterinary sector. Two veterinarians were used 
in the pilot, and the questions were amended as appropriate. 
Timeline: The survey was open on the 1st of October 2019 till the 31st of October 2019. A 
reminder was sent two weeks into the opening of the survey. Responses received after the 31st 
of October were not considered.  
 
1.3.4.4 Data Collection Process: 
Assistance in distributing the survey to their membership on behalf of the principal investigator 
was sought from the SAVA and SAALAS. The two associations then distributed the link for the 
survey to all veterinarians, veterinary nurses, animal health technicians, and laboratory animal 
technicians on their databases via email.  
Upon receiving the link, participants were directed to a specific website containing the 
questionnaire. Informed voluntary consent was obtained from all the participants in the 
preamble to the questionnaire. Upon completion of the questionnaires, responses were then 
recorded automatically.  
 
1.3.4.5 Data analysis 
Data was entered on the Microsoft Excel spreadsheet and analysed using commercial statistical 
software (SAS, version 9.4, SAS Institute Inc, Cary, NC). Variables were analysed using 
descriptive statistics and presented as percentages at 95% confidence intervals. Before analysis, 
responses to the questions were merged as follows: for knowledge, “very important” and 
“extremely important” responses were merged into one variable as were “strongly agree” and 
“agree,” “strongly disagree” and “disagree,” “not at all” and “a little,” and “quite a bit” and 
“very much”; while for attitudes, “not concerned” and “slightly concerned,” “quite concerned” 
and “very concerned,” “strongly disagree” and “disagree” and “agree” and “strongly agree” 
41 
 
were merged as one variable. For practices, “very important” and “extremely important” were 
merged as one variable; this was also true for “never” and “rarely” and “very often” and 
“always.” The merged variables were then statistically analysed. Knowledge-related statements 
on antibiotic resistance carried a total score of 13 and a 50% score (6.5) was used to classify the 
respondent as knowledgeable. Correctly identifying contributors to antibiotic resistant infections 
in people and factors in veterinary medicine leading to antibiotic resistant infections carried a 
score of 5 and 7 respectively. The Independent t-test (comparing mean values of only two 
groups) and the analysis of variance (ANOVA) with Tukey multiple comparison (comparing 
mean values of more than two groups) were then used to establish associations between the 
knowledge variables and socio-demographics. The criterion for statistical significance was set at 
a 5% level. 
1.4 STUDY OUTLINE 
This study aimed to determine the knowledge, attitudes and practices of animal health 
professions on antibiotic use, ABR, and its containment in the South African veterinary sector. 
The research is presented in three chapters, as follows: 
Chapter 1 provides the background, literature review, rationale, aims and objectives for the 
study and an overview of the study design and research methodology.  
Chapter 2 provides results of the KAP study conducted within SA in the form of a manuscript 
prepared for the Journal of the South African Veterinary Association. 
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The inappropriate use of antibiotics in the veterinary sector has contributed to antibiotic 
resistance (ABR), which negatively impacts animal health and welfare. Understanding the 
knowledge, attitudes, and practices on antibiotic use, ABR, and its containment amongst 
veterinarians is critical to optimize antibiotic use and contain resistance. 
A quantitative questionnaire-based online survey was conducted amongst members of 
professional veterinary associations. The questionnaire consisted of four sections focusing on 
socio-demographic characteristics, knowledge, attitudes, and practices (KAP) of participants on 
antibiotic use, ABR, and its containment in the South African veterinary sector. The 
Independent t-test, analysis of variance (ANOVA), and Chi-square test were used to establish 
associations among selected socio-demographic variables and selected KAP parameters.   
A total of 130 responses were received from 2178 animal health professionals, yielding a 
response rate of 6 %, with 102 complete responses constituting the final sample size. Self-
reported knowledge on antibiotic stewardship, antibiotic resistance mechanisms, and 
pharmacology was good at 96 (94.1%), 91 (89.2%), and 70 (68.6%), respectively). Most 
respondents (81 [79.4%]) believed that antibiotics were sometimes prescribed for suspected but 
not confirmed infections. Veterinary guidelines for appropriate use of antibiotics were 
sometimes read by most respondents (45 [44.1%]). Notably, most of the veterinarians (61 
[59.8%]) also lacked an antibiotic stewardship programme at their practice. Place of practice 
was significantly associated (p=0.004) with possession of knowledge about antibiotic resistance. 
Veterinarians in urban practice were more knowledgeable about antibiotic resistance than those 
in rural practice. Place of practice was also significantly associated (p=0.035) with discussions 
on antibiotic resistance with clients. More veterinarians in rural practice frequently carried out 
such discussions than their urban counterparts. 
Antibiotic stewardship programmes need to be implemented in veterinary practice. Such 
programmes might encourage the frequent use of consensus guidelines for the appropriate  use 








Inappropriate antibiotic prescribing and increased antibiotic consumption in animals have 
contributed to antibiotic resistance (ABR) (Reygaert 2018). Human health is negatively 
impacted by ABR in animal health as observed in resistance to colistin due to its use in animal 
production. Colistin is an antibiotic of last resort in humans for the treatment of infections 
caused by multidrug-resistant Gram-negative bacteria (Rhouma, Beaudry & Letellier 2016). 
Loss of antibiotic efficacy compromises human therapy (Van Vuuren, Picard & Greyling 2007). 
Antibiotic use in animal health applies a selective pressure that favours ABR emergence and 
spread (Chantziaras et al. 2014; Pomba et al. 2017), limiting treatment options for infections in 
animals and resulting in treatment failure that negatively affect food production, livelihoods, 
and food security (Food and Agriculture Organisation [FAO] 2019). It is estimated that by 
2050, an 11% drop in animal productivity is set to occur due to ABR (World Bank 2017). Loss 
of antibiotic efficacy due to resistance will also have a negative impact on animal health and 
welfare. Damage to the tissues and organs canoccur as a result of bacterial infections, and there 
is a high risk of disease outbreaks and the dissemination of zoonotic bacteria. The problem is 
further exacerbated by a lack of new antibiotics that are specifically being produced for animal 
health (Vaarten 2012).  
The Global Action Plan (GAP) on Antimicrobial Resistance (AMR) was adopted by the World 
Health Assembly in 2015 (World Health Organisation [WHO] 2015). This was a joint initiative 
of the tripartite alliance of the WHO, World Organisation for Animal Health (OIE) and the FAO 
of the United Nations (WHO 2015). In support of the GAP, the OIE aims to increase awareness 
and understanding and enhance knowledge via surveillance and research among its strategic 
objectives. Information materials targeting veterinarians and other stakeholders will be 
developed to understand ABR risks. A professional culture that ensures appropriate antibiotic 
use in animal health will be encouraged via veterinary institutions and veterinary governing 
bodies. OIE guidelines, scientific and educational materials used for reference in mitigating the 
development and dissemination of antibiotic resistant organisms will be expanded while 
simultaneously encouraging efficient disease prevention measures to avoid unnecessary 
antibiotic use in animals (World Organisation for Animal Health [OIE] 2016a). Also in support 
of GAP, FAO focuses on key areas that include improving the level of awareness on ABR and 
its associated threats and developing capacity for ABR and antibiotic use surveillance and 
monitoring in food and agriculture. FAO also focuses on promoting good practices in systems 
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of food and agriculture and appropriate antibiotic use. Knowledge of ABR and antibiotic use 
will also be improved by developing educational materials, promoting research and contributing 
to continuing education, professional education, post graduate training and certification (FAO 
2016). 
Veterinarians are responsible for prescribing and administering antibiotics to animal patients 
and are critical to appropriate antibiotic use in animal health. We therefore conducted an online 
questionnaire-based survey to determine the knowledge, attitudes and practices of veterinarians 
on antibiotic use, resistance, and its containment in South Africa in order to inform 
interventions to optimize use and contain resistance. 
Materials and Methods 
Ethical Considerations 
Ethical approval was obtained from the Biomedical Research Ethics Committee of the 
University of Kwa-Zulu Natal (Reference No.: BE033/19). Informed voluntary consent was 
obtained from all the participants in the preamble to the questionnaire. 
Study Design 
A quantitative questionnaire-based online survey was conducted amongst members of the South 
African Veterinary Association (SAVA) and the South African Association for Laboratory 
Animal Science (SAALAS) whose members are veterinarians, veterinary nurses, veterinary 
nurses, animal health technicians and veterinary technologists. SAVA and SAALAS 
disseminated a link to the questionnaire to their membership via email. The survey was open 
from the 1st of October 2019 till the 31st of October 2019.  
Survey instrument 
Data was collected using an online self-administered questionnaire (supplementary material) 
compiled from four questionnaires used in previous similar studies (University of Colorado 
Denver 2018; Hardefeldt et al. 2018; Sadiq et al. 2018; Ekakoro & Okafor 2019). The 
questionnaire was divided into four sections consisting of closed-ended questions (yes or no) 
and Likert style (strongly agree/agree/neutral/disagree/strongly disagree) questions. Section 1 
focused on the socio-demographic characteristics of participants and sections 2-4 dealt with 
knowledge, attitudes, and practices of participants on antibiotic use, ABR, and its containment 
in the South African veterinary sector. Two veterinarians were used in the pilot, and the 




Data was entered on the Microsoft Excel spreadsheet and analysed using commercial statistical 
software (SAS, version 9.4, SAS Institute Inc, Cary, NC). Variables were analysed using 
descriptive statistics and presented as percentages at 95% confidence intervals. Before analysis, 
responses to the questions were merged as follows: for knowledge, “very important” and 
“extremely important” responses were merged into one variable as were “strongly agree” and 
“agree,” “strongly disagree” and “disagree,” “not at all” and “a little,” and, “quite a bit” and 
“very much”; while for attitudes, “not concerned” and “slightly concerned,” “quite concerned” 
and “very concerned,” “strongly disagree” and “disagree” and “agree” and “strongly agree” 
were merged as one variable. For practices, “very important” and “extremely important” were 
merged as one variable; this was also true for “never” and “rarely” and “very often” and 
“always.” The merged variables were then analysed using the Chi-square test.  Knowledge-
related statements on antibiotic resistance carried a total score of 13 and a 50% score (6.5) was 
used to classify the respondent as knowledgeable. Correctly identifying contributors to 
antibiotic resistant infections in people and factors in veterinary medicine leading to antibiotic 
resistant infections carried a score of 5 and 7 respectively. The Independent t-test (comparing 
mean values of only two groups) and the analysis of variance (ANOVA) with Tukey multiple 
comparison (comparing mean values of more than two groups) were then used to establish 
associations between the socio-demographic variables and KAP parameter. The criterion for 
statistical significance was set at 0.05. 
Results 
In total, 130 responses were received from 2178 animal health professionals (response rate 
6%); all of whom were veterinarians. Among the 130 responses received, only 102 responses 
were fully complete and constituted the final sample. From the 102 responses that underwent 
analysis, 49 (48%) were female, and 53 (52%) were male. Seventy (68.6%) of the respondents 
were more than 40 years in age, while 32 (31.4%) were aged between 20 and 40. Fifty 
respondents (49%) had more than 20 years of veterinary experience, while 34 (33.3%) had less 
than 11 years of veterinary experience. Thirty-eight (37.3%) of the respondents were registered 
as specialists, 64 (62.7%) practised in an urban setting and 38 (37.3%) practised in a rural 
setting (Table 1). The vast majority of respondents (74.5%) were in general small/mixed animal 
practice and two-thirds spent 80-100% in clinical practice. Gauteng province had the highest 
number of respondents at 42 (41.2%) followed by Western Cape with 24 (23.5%) and Kwa-
Zulu Natal with 15 (14.7%). Ninety-three (91.2%) of the respondents obtained their veterinary 
qualifications at the University of Pretoria while 9 (8.8%) attended other universities. Table 1 
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shows selected socio-demographic data used in statistical analysis with complete socio-
demographic data  contained in the supplementary table (S1). 
 
 
Table 1: Selected socio-demographics of veterinary participants (n=102). 









Years in veterinary practice 
 
 0-10 years 
11-20 years  








     20-40 years 





Registered as Specialists 
 
38(37.3) 










Participants had good knowledge of antibiotic resistance (Table 2). Based on a total score of 13, 
the average score for the respondents was 11.57± 1.33). Veterinarians in urban practice were 
more knowledgeable about antibiotic resistance (11.86±1.00) compared to those in rural 
practice (11.08±1.67). The average score on contributors to antibiotic resistant infections in 
people was low (Based on a total score of 5, the respondents’ average score was 1.99±1.13). 
The average score on selecting factors in veterinary medicine that may play a role in antibiotic 
resistant infections in people was relatively good (Based on a total score of 7, the average score 
for the respondents was 3.95±1.17). All the respondents were aware that drug resistant 
infections could be difficult to treat and they also believed that antibiotics should be prescribed 
by veterinarians only when necessary. Almost all of the respondents recognised the danger 
antibiotic resistant infections posed on surgical procedures. About 73% of the respondents 
recognised antibiotic resistance as one of the biggest problems in livestock production. More 
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than 60% of the respondents recognised that antibiotics should not be stored for later use in 
animals, i.e., bottles of antibiotic solutions for injection, once opened, need to be discarded after 
28 days. Of note was that 6% of the participants believed that antibiotic resistance is not an 
issue in South Africa.  
 
 
Table 2. Knowledge of antibiotic resistance (n=102). 
Item Number (%) of responses 
There is an increasing rate of infections resistant to 
antibiotics in animals 
98(96.1) 
Infections from antibiotic resistant bacteria could be 
difficult to treat 
102(100) 
Antibiotic resistance can greatly affect the animal 
population 
97(95.1) 
Antibiotic resistance is not an issue in South Africa 6(5.9) 
Antibiotic- resistant bacteria can spread from animal to 
animal 
95(93.1) 
Antibiotic resistance in animals can spread to humans 92(92.9) 
Infections from antibiotic resistant bacteria can make 
surgical procedures dangerous 
101(100) 
Antibiotics should not be stored for later use in animals 56(67.5) 
Appropriate antibiotic use can reduce the risk of antibiotic- 
resistant bacterial infections in animals 
98(96.1) 
The antibiotic resistance problem can be reduced by good 
biosecurity 
80(93) 
Antibiotics should only be administered to animals when 
prescribed by veterinarians 
99(97.1) 
Antibiotic resistance is one of the biggest problems in 
livestock production 
64(72.7) 
Veterinarians should only prescribe antibiotics when 
necessary 
102(100) 
Only Yes responses are included in the table  
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None of the veterinarians thought antibiotics were warranted in ecto-parasite infestation while 
80 (78.4%) and 98 (96.1%) thought they were necessary for skin infection and respiratory tract 
infection respectively. Thirty-one (30.4%) thought they were necessary in diarrhoea and 32 
(31.4%) thought the same for fever (Supplementary Table S2). The narrow-spectrum antibiotics 
amoxicillin and procaine penicillin were identified as first-line treatment by 79 (77.5 %) and 50 
(49%) respondents, respectively. Most respondents identified other broad-spectrum antibiotics 
such as amoxicillin-clavulanate (62 [60.8%]) and metronidazole (64 [62.7%]) as first-line, while 
a few identified rifampicin (1 [1%]), amikacin (2 [2%]), and marbofloxacin (5 [4.9%]) as first-
line (Figure 1a). Penicillins were prescribed most often by most respondents (72 [70.6%]), 
while aminoglycosides were less-frequently prescribed (46 [45.1%]) (Figure 1b). Notably, a 
majority never administered or prescribed the antibiotics linezolid (102 [100%]), vancomycin 
(99 [97.1%]), and imipenem (96 [94.1%]). However, most respondents (72 [70.6%]) had 
prescribed Polymyxin B (Terra-cortril® and or Surolan®) at some point in time. 
 
 
 Figure 1: Antibiotic prescribing.  1A: lines of treatment; 1B: frequency of prescribing the major 
classes of antibiotics; 1C: five most commonly prescribed antibiotics 
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Generally, the respondents asserted that they had good knowledge of the pharmacology of 
antibiotics (70 [68.6%]) and appropriate antibiotic use that minimises the development of 
antibiotic resistance (83 [81.4%]). This was also articulated in relation to understanding 
antibiotic stewardship (96 [94.1%]) and antibiotic resistance mechanisms (91 [89.2%]) 
(Supplementary Figure 1). More than half the respondents were confident that their veterinary 
training equipped them quite a bit/very much (60 [58.8%]) on knowledge on rational antibiotic 
use. A majority of the respondents (91 [89.2%]) were interested in obtaining continuing 
professional education on antibiotic use, resistance, or stewardship while a few were not sure (8 
[7.8%]). Only three (2.9%) were not interested in obtaining continuing professional education. 
The veterinary formulary, peer-reviewed scientific literature and textbooks or drug handbooks 
were considered to be the most important sources of information on antibiotics by 83 (81.4%), 
82 (80.4%) and 80(78.5%) of the participants respectively (Supplementary Figure 2). 
 
Attitudes 
A majority of the respondents (81 [79.4%]) believed that antibiotics were sometimes prescribed 
for suspected but not confirmed infections. Fifteen (14.7%) believed antibiotics were prescribed 
based on confirmed infection, while six (5.9%) believed antibiotics were sometimes prescribed 
based on no documented evidence of infection. A little more than half (56 [54.9%]) the 
respondents believed that antibiotics were optimally prescribed, 45 (44.1%) believed that 
antibiotics were overprescribed and one respondent (1%) believed antibiotics were under-
prescribed at their practice (Supplementary Figure 3). The concern related to antibiotic resistant 
infections amongst veterinarians was inverted amongst their clients (Figure 2) with the majority 
of the respondents (77 [75.5%]) being quite concerned/very concerned about antibiotic resistant 




The cost of diagnostics (90 [88.2]), time to results of diagnostics (83 [81.4%]), and client 
expectations of receiving antibiotics (74 [72.5%]) were the most prominent barriers to 
implementing an antibiotic stewardship plan in their veterinary practices. 
Practices and Experiences 
Persistent infection (89 [87.3%]), recurring infections (73 [71.6%]), and client finances (48 
[47.1%]) were the most important factors in influencing the decisions of veterinarians to submit 
samples for microbial culture and susceptibility testing. Results of bacteriological culture and 
antibiotic susceptibility (86 [84.3 %]), animal owner compliance to the prescription (77 
[75.5%]), clinical signs (75 [73.5%]) and appropriate use guidelines (73 [71.5%]) were 
considered to be very important in determining the need for and choice of antibiotics while 
pressure from clients (76 [74.5%]), fear of litigation by the animal owner in the event of an 
undesirable outcome (72 [70.5%]) and concern about antibiotic resistant infections in humans 




Table 3. Statistically significant associations between selected socio-demographic factors and 




The extent of agreeing on antibiotic drug use in 
veterinary practice leading to antibiotic resistance in 










 N % N % N %  
Veterinary experience 
0-10 years 3 8.8 5 14.7 26 76.5 
 
0.006* 
11-20 years 4 22.2 7 38.9 7 38.9 
+ 20 years 7 14.0 3 6.0 40 80 
Frequency of discussing antibiotic resistance with clients. 
 Never/rarely Sometimes Often/always  
 N % N % N %  
Place of practice        
Rural 6 15.8 7 18.4 25 65.8 
0.035* 
Urban 6 9.7 27 43.5 29 46.8 










 N % N % N %  
Gender        
Female 30 63.8 11 23.4 6 12.8 
0.000* 
Male 11 21.6 27 52.9 13 25.5 
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Client finances as an influence on the decision to submit samples for culture and sensitivity 
 No Yes  
 N % N %  
Gender      
Female 18 36.7 31 63.3 
           0.002* 
Male 36 67.9 17 32.1 
Age      
20-40 12 37.5 20 62.5 
           0.035* 
+40 42 60 28 40 
Veterinary experience 
0-10 years 12 35.3 22 64.7 
0.003* 11-20 years 7 38.9 11 61.1 
+20 years 35 70 15 30 
 
Knowledge on antibiotic resistance was significantly higher amongst veterinarians in urban 
practice (p=0.004) (Supplementary Table 3). Rating client concerns on antibiotic resistance was 
significantly associated with gender (p=0.000) (Table 3). The frequency of discussing antibiotic 
resistance with clients was significantly associated with place of practice (p=0.035) (Table 3). 
The extent of agreeing on antibiotic drug use in veterinary practice leading to antibiotic 
resistance in pathogens affecting humans was significantly associated with veterinary 
experience (p= 0.006) (Table 3). Client finances as an influence on the decision to submit 
samples for culture and sensitivity was significantly associated with gender (p=0.002), age 
(p=0.035) and experience (p=0.003) (Table 3). 
Discussion  
A quantitative questionnaire-based online survey was conducted among veterinarians in South 
Africa. Average knowledge scores on antibiotic use, antibiotic-resistance, and its containment in 
animal health in South Africa were good. The veterinary training the respondents received 
appeared to equip the vast majority of respondents with adequate knowledge on the rational use 
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of antibiotics. There was a high degree of concern about antibiotic resistant infections. The 
veterinarians sometimes consulted veterinary guidelines for appropriate use of antibiotics, and 
penicillins (procaine penicillin, amoxicillin, amoxicillin-clavulanate) were the most preferred 
antibiotic class.  
Veterinarians in urban practice were more knowledgeable about antibiotic resistance than those 
in rural practice (p=0.004). This may be due to fewer ABR awareness campaigns targeting the 
rural areas as compared to urban areas. From the results, a few of the respondents believed that 
ABR is not an issue in South Africa. ABR is not only a threat in South Africa but worldwide. 
This is evident in efforts to address ABR in the form of the South African National Strategy 
Framework (locally) (Department of Health [DoH] 2018) and the FAO and OIE action plans 
(internationally) (FAO 2016; OIE 2016a). Having a belief that ABR is not a threat might hinder 
the implementation of antibiotic stewardship programmes in animal health, thus worsening 
ABR, as was evident in this study where few respondents had antimicrobial stewardship 
programmes in their practices. Antibiotic stewardship refers to approaches that encompass 
correct antibiotic usage, dosage, and duration whilst preventing antibiotic resistance. It involves 
the use of guidelines for appropriate use of antibiotics, culture and sensitivity testing before 
antibiotic usage, surveillance and monitoring of antibiotic usage, client education, and the 
implementation of effective infection prevention and control programmes (Guardabassi & 
Prescott 2015).   
Generally, the respondents asserted that they had good knowledge of antibiotics’ pharmacology, 
appropriate antibiotic use that minimises the development of antibiotic resistance, antibiotic 
stewardship and antibiotic resistance mechanisms. This is in contrast to a study done in 2017 in 
Nigeria to assess the perceptions, knowledge, and practices of antibiotic stewardship among 280 
veterinarians in Enugu state. In the study, few respondents had heard about antibiotic 
stewardship (17.1%), and overall knowledge on the matter was poor (21.4%) (Anyanwu & 
Kolade 2017). Such differences in the two studies could be attributed to recent antibiotic 
stewardship implementation efforts in animal health. Instituting antibiotic stewardship 
programmes at curricular and practice level will enable appropriate use of antibiotics, thus 
aiding in minimising ABR emergence and spread. However, effective implementation might be 
hindered by poor use of microbial culture and susceptibility tests, absence of well-trained 
veterinary professionals on antibiotic stewardship, gaps in knowledge on current resistance 
patterns and the lack of evidence-based guidelines (Guardabassi & Prescott 2015).  
To a greater extent, the respondents from our study believed the veterinary training they 
received adequately equipped them with knowledge on rational antibiotic use. One would have 
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expected the recent prioritisation of ABR on the public health agenda to cause disparities 
between recently graduated veterinarians and their counterparts with more veterinary 
experience. However, this was not the case in this study. Adequate knowledge of rational 
antibiotic use combined with the right attitude will enable best practice and effective ABR 
containment strategies. However, adequate training alone on rational antibiotic use might not 
translate to appropriate antibiotic use. Gaps might exist in the application of theoretical aspects 
in practice (Smith et al. 2019). This might have been the case in our study, where respondents 
identified some broad-spectrum antibiotics as first-line. Knowledge of rational antibiotic use 
should be among the priority areas in continuing professional development and postgraduate 
veterinary studies (Smith et al. 2019).  
In our study, most respondents were concerned about ABR. It is worth noting that the GAP on 
AMR was published in 2015 and followed by the OIE and FAO action plans in 2016. Such 
initiatives could have managed to raise awareness on the implications of antibiotic resistant 
infections in animal health, thus leading to a high level of concern among veterinarians, concern 
that is necessary for the effective implementation of antibiotic stewardship programmes and 
effective ABR containment strategies. Combined with adequate knowledge, it will also favour 
practices that help preserve the existing finite antibiotic arsenal. Generally, the veterinarians 
viewed their clients as being slightly concerned over antibiotic resistant infections. This may be 
due to a low frequency of discussions with clients over the ABR matter. It could have also been 
due to the lack of clarity when discussions on the matter were held with veterinarians. In our 
study, veterinarians sometimes discussed antibiotic resistance with their clients. A more 
significant percentage of veterinarians in rural practice frequently carried out such discussions 
than their urban counterparts (p=0.035). Such disparities might be influenced by an over-
reliance on antibiotics in clients from rural areas compared to those in urban areas, hence the 
need for frequent discussions in those areas. Busy schedules due to high patient loads might 
hinder such discussions from taking place. Discussing ABR with the clients will assist in raising 
awareness on the subject. This will help ensure that clients adhere to antibiotic dosages 
stipulated by veterinarians for their animals, thus, averting client practices that favour ABR 
emergence and spread.  
In our study, most respondents believed that antibiotics were sometimes prescribed for 
suspected but not confirmed infections regardless of bacteriological culture and antibiotic 
susceptibility importance. This suggests that an empiric approach to treatment could be 
preferred compared to a microbiology guided approach in some instances. Microbiology forms 
an integral part of antibiotic stewardship with microbial culture and susceptibility testing as part 
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of the diagnostic testing (Guardabassi & Prescott 2015). Notably, most respondents indicated 
the cost of diagnostic testing, time to results of diagnostics and client expectations of receiving 
antibiotics as barriers to the implementation of antibiotic stewardship programmes. As expected, 
client finances were among the important factors that could influence the submission of samples 
for microbiological investigations. All these factors combined could be responsible for such an 
empiric approach to antibiotic treatment. Microbiology guided treatment would be preferable to 
empiric treatment. This is because it aids the veterinarian in choosing an ideal antibiotic in an 
infection, thus preserving the currently available antibiotic arsenal and maintaining animal 
welfare in the process (Watts, Sweeney & Lubbers 2018).   
Most respondents read guidelines for appropriate use of antibiotics. The use of any veterinary 
formulary, peer-reviewed scientific literature, textbooks or drug handbooks were chosen as the 
most important sources of information in determining antibiotic choice for clinical use. The 
results are almost similar to a study done at a veterinary teaching facility in the USA among 
veterinary clinicians. In that study, the respondents chose peer- reviewed scientific literature 
(56.5%) and textbook or drug handbook (24.2%) as the most important sources of information 
(Ekakoro & Okafor 2019).  Conversely, in a study done in Australia among veterinarians in 
companion animal medicine, only 36% of them used peer-reviewed literature as an information 
source (Hardefeldt et al. 2017). The use of peer-reviewed literature, drug handbooks, and 
formularies assists in ensuring appropriate antibiotic use. It can also control the use of 
antibiotics designated to be critically important for both human and veterinary medicines (De 
Briyne et al. 2014). Consequently, this may assist in curbing the further emergence and 
dissemination of ABR. One major drawback is that the use of information from such sources 
may not be based on local resistance surveillance data. Currently, a national antimicrobial 
surveillance programme is yet to be reintroduced in the South African animal health sector 
(DoH 2018). The use of local resistance surveillance data is imperative in order to guide in 
antibiotic prescribing in a manner that minimises ABR dissemination while optimising on 
antibiotic choice. Notably, antibiotic classes and their respective antibiotic agents which are of 
clinical importance both in human and veterinary medicine must be included in monitoring 
programmes to help preserve their efficacy. This entails using the WHO list of critically 
important antibiotics and the OIE list of antibiotics of veterinary importance (OIE 2015). 
Most respondents prescribed antibiotics for pre-operative prophylaxis and the prevention of 
post-operative infections. Avoiding prophylactic antibiotic use is necessary to minimise the 
selection of resistant bacteria and possible transfer. However, prophylactic use of antibiotics can 
be implemented in high infection risk cases and where the infection consequences are grave. 
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Such cases include surgical procedures with a duration of more than one and a half hours and 
surgery involving a break in asepsis. Prophylactic antibiotic use is also indicated in surgery of 
the central nervous system, gastrointestinal tract, and contaminated wounds (Ramsey 2017). 
Although the cases in which antibiotics were indicated for pre-operative prophylaxis and the 
prevention of post-operative infections were not assessed in our study, appropriate prophylactic 
antibiotic use should still be encouraged among veterinarians. 
A number of the respondents believed antibiotics were necessary in both diarrhoea and fever 
cases from our study. Diarrhoea cases do not generally require antibiotic therapy unless the 
identification of a specific bacterial causative agent has taken place or haemorrhage due to 
intestinal ulceration is observed (Battersby & Harvey 2006). Antimicrobial stewardship 
programme implementation might help ensure that proper diagnostic approaches are followed to 
prevent unnecessary antibiotic use. 
Antibiotics that were regarded as the first-line by many respondents were generally the 
frequently prescribed antibiotics classes. A majority of these antibiotics fall under the OIE list 
of antibiotics of veterinary importance. These drugs are important in specific infections and 
have to be preserved because of the few alternatives available (OIE 2019). Impressively, most 
respondents never prescribed linezolid, vancomycin, and imipenem. These drugs fall under the 
WHO list of critically important antibiotics. Most respondents had however prescribed 
polymyxin B at some point in time (WHO 2019). 
It should be noted that polymyxin B is structurally similar to colistin and both fall under the 
polymyxin class of antibiotics. In 2016, the WHO list of critically important antibiotics 
underwent revision, and polymyxins were re-classified into critically important antimicrobials 
of the highest priority. The re-classification came after an increase in colistin use in the 
treatment of severe human infections the world over, the discovery of genes that confer 
resistance to colistin on plasmids (mcr genes), and the dissemination of colistin-resistant 
bacteria through the food chain (WHO 2019). OIE thus set the following recommendations on 
the use of colistin: (1) it should not be used to prevent infection nor be administered through 
water or feed without clinical signs in the animal(s) proposed to receive treatment, (2) use as a 
first-line antibiotic should be justified and use as a second-line antibiotic should be based on 
bacteriological test results, (3) its off label use must be restricted, and, in such instances, it 
should be used in the absence of alternatives and should be in line with the current national 
legislation, and (4) use in growth promotion is prohibited  (OIE 2019). In our study, many 
respondents considered the broad-spectrum antibiotics amoxicillin-clavulanate and 
oxytetracycline to be first-line. Narrow-spectrum antibiotics should be preferred to broad-
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spectrum antibiotics in first-line treatment because broad-spectrum antibiotics are more likely to 
promote ABR emergence (Da Silva, Knöbl & Moreno 2013).  
Our results are similar to those observed among veterinarians at a USA veterinary teaching 
facility in a 2017 study where penicillins were frequently prescribed and preferred to other 
antibiotic classes of medical importance (Ekakoro & Okafor 2019). The OIE has also provided 
some useful insight in its annual reports on antibiotic usage in animals that have been published 
since 2016. The reports are intended to create a clear understanding of antibiotic use in animals 
from a global perspective, which can assist in providing effective containment strategies (OIE 
2016b). In these reports, data was collected from OIE and non-OIE members through the use of 
templates and guidance documents developed by OIE and tested among member countries. The 
templates determined antibiotic classes sold or used for growth promotion and therapy for all 
animal species in kgs of active ingredient (OIE 2016b; OIE 2017; OIE 2018). According to data 
collected between 2012 and 2015 from 34 European OIE member states, penicillins accounted 
for a third (34%) of all antibiotics used in animals (OIE 2016b). Penicillins constituted almost 
30% of all antibiotic classes used in animals from data collected from 107 countries between 
2013 and 2016 (OIE 2017). Furthermore, data collected in 116 countries between 2015 and 
2017 showed tetracyclines (34.5%) to be the most commonly reported antibiotic class followed 
by penicillins making up 15.2% of the total proportion of antibiotic classes used in animals 
(OIE 2018). Penicillins are currently classified under critically important antibiotics by the OIE. 
They are important in the management of potential life threatening animal conditions such as 
urinary tract infections and septicaemias, where alternative cost-effective antibiotics are few 
(OIE 2019). Penicillins are also currently classified under medically important antibiotics in 
human medicine by the WHO (WHO 2019). Frequent prescribing of penicillins and all other 
antibiotics exerts selection pressure for resistance development which poses a serious human 
and animal health risk world over. It is thus vital that veterinary prescribers exercise due 
diligence when prescribing all antibiotics. 
Conclusion 
From our study, gaps in the knowledge, attitudes, and practices on antibiotic use, antibiotic 
resistance, and its containment were identified. Knowledge of rational antibiotic use and ABR 
should be included in continuing professional development programmes to address such gaps in 
different geographical locations. Antibiotic stewardship programmes need to be implemented in 
veterinary practice, cost-effective diagnostic tests with shorter turnaround time might assist in 
achieving such. Antibiotic stewardship programmes might encourage the frequent use of 
guidelines for the appropriate use of antibiotics and microbiology informed therapy. Client 
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education on ABR is imperative; more discussions between veterinarians and their clients over 
ABR are necessary to help change client attitudes. There is a need for veterinarians to use 
narrow-spectrum antibiotics as first-line drugs where possible. Use of the OIE list of veterinary 
important antibiotics and the WHO list of medically important antibiotics should be encouraged 
to conserve the antibiotics of critical importance. Veterinarians need to be proactive in reporting 
adverse antimicrobial drug events together with suspected lack of efficacy antibiotics which 
may be attributed to ABR to the respective pharmaceutical companies. Such reporting will help 
the pharmaceutical industry to investigate increasing trends in ABR to their products and act 
accordingly. 
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SURVEY FOR VETERINARY PERSONNEL 
INFORMED CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
Dear Colleague, 
We kindly request your participation in a survey amongst animal health professionals. The aim is to 
determine the knowledge, attitudes, practices and experiences of veterinary/animal health professions 
(veterinarians, veterinary nurses, animal health technicians, veterinary technologists) on antibiotic use, 
antibiotic resistance (ABR) and its containment in animal health in South Africa. 
Antibiotics are substances that either kill or inhibit bacteria. Antibiotic resistance occurs when bacteria are 
unaffected by the antibiotic agents which were initially effective in curing the infections caused by the 
bacteria. 
The Objectives of the study are; 
• To determine the level of knowledge of animal health professionals on antibiotic use, antibiotic 
resistance (ABR) and its containment in animal health in South Africa. 
• To understand the attitudes of animal health professionals on antibiotic use, antibiotic resistance 
(ABR) and its containment in animal health in South Africa. 
• To determine the experiences and practices of antimicrobial stewardship programmes of animal 
health professionals towards antibiotic resistance containment in South Africa. 
Your participation in this study involves answering questions about antibiotics, antibiotic use, antibiotic 
resistance and antibiotic stewardship. The questions will be open-ended and closed ended. Please be 
aware that where a question does not apply to a certain profession the option ‘not applicable’ is available 
as a response. 
Please be advised that; 
• No identifying information will be stored or disseminated. 
• All answers are anonymous, and all responses will be aggregated before analysis. 
• Confidentiality and anonymity are guaranteed by the electronic survey format. 
• Your participation is entirely voluntary and, you are free to decline participation. 
• There are no known risks in participating in this study. 
• This research study has been granted ethical clearance from the UKZN Biomedical Research 
Ethical Committee (BREC Ref No: BE033/19) 
BREC can be contacted on:  BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
                                               Research Office, Westville Campus 
                                               Govan Mbeki Building 
                                               Private Bag X54001 
                                               Durban, 4000 
                                               KwaZulu- Natal, SOUTH AFRICA 
                                              Telephone: 0027 31  260 2486- Fax: 0027 31 260 0460 
                                               Email: BREC@ukzn.ac.za 
 





Thank you in advance for your participation. If you have any questions or queries, please feel free to 
contact the Researcher: Simbai Allen Maruve, Bachelor of Veterinary Science on 
218088135@stu.ukzn.ac.za 
We thank you in advance for your participation. 
Yours faithfully 
Simbai Allen Maruve 
  
There are 44 questions in this survey 
SECTION 1. SOCIO-DEMOGRAPHIC 
CHARACTERISTICS OF PARTICIPANTS 
What is your gender? * 
Please choose only one of the following: 
•  Female 
•  Male 
What age group do you fall under? * 
Please choose only one of the following: 
•  20-25 years 
•  26-30 years 
•  31-35 years 
•  36-40 years 
•  41-45 years 
•  46-50 years 
•  51-55 years 
•  56-60 years 




What is your profession? * 
Please choose only one of the following: 
•  Veterinarian 
•  Veterinary nurse 
•  Animal health technician 
•  Veterinary technologist 
•  Laboratory animal technologist 
•  Animal welfare assistant 
•  Veterinary physiotherapist 
What is your qualification? * 
Please write your answer here: 
  
At which university/institution did you obtain the 
qualification? * 
Please choose only one of the following: 
•  University of Pretoria 
•  Medical University of Southern Africa (MEDUNSA) 
•  University of South Africa (UNISA) 
•  Tshwane University of Technology 
•  North West University 
•  Tsolo Agricultural and Rural Development Institute (TARDI) 







Which of the following describes the period of your 
graduation from the university/institution mentioned 
above? * 
Please choose only one of the following: 
•  Prior to 1950 
•  1951 - 1960 
•  1961 - 1970 
•  1971 - 1980 
•  1981 - 1990 
•  1991 - 2000 
•  2001 - 2010 
•  2011 - 2019 
What best describes your current employment 
setting? * 
Please choose all that apply: 
•  General small animal practice 
•  General mixed animal practice 
•  Emergency practice 
•  Specialty practice 
•  Animal welfare 
•  Feline only practice 
•  Mobile practice 
•  Academic teaching hospital 
•  Locum 
•  Wildlife 
•  Retired 
•  Unemployed 
•  Other (i.e Government Industry) 
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Are you registered with the South African Veterinary 
Council (SAVC) as a specialist? * 
Please choose only one of the following: 
•  Yes 
•  No 
Do you have any field of specialization? * 
Please choose only one of the following: 
•  No field of specialization 
•  State/ regulatory veterinary medicine 
•  General pathology practice 
•  Clinical pathology practice 
•  Ophthalmology 
•  Radiology and veterinary imaging 
•  Rehabilitation and physiotherapy 
•  Soft tissue surgery 
•  Orthopaedic surgery 
•  Avian, exotic and zoological medicine 
•  Neurology 
•  Internal medicine 
•  Emergency/critical care/ICU 
•  Dermatology 
•  Cardiology 
•  Anaesthesia 
•  Behavioral medicine 
•  Dentistry 
•  Laboratory diagnostic practice 
•  Rural practice - food animal 
•  Equine practice 
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•  In - hospital food animal 
•  Theriogenology 
•  Other  
How many years have you been in veterinary 
practice? * 
Please choose only one of the following: 
•  < 1 year 
•  1-5 years 
•  6-10 years 
•  11-15 years 
•  16-20 years 
•  21-25 years 
•  26-30 years 
•  > 30 years 
What proportion of your total professional activity is 
dedicated to clinical practice? * 
Please choose only one of the following: 
•  Less than 20% 
•  20-39% 
•  40-59% 
•  60-79% 
•  80-100% 
Where do you practice? * 
Please choose only one of the following: 
•  Urban 
•  Rural 
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In which Province do you practice? * 
Please choose only one of the following: 
•  Gauteng 
•  North West 
•  KwaZulu Natal 
•  Eastern Cape 
•  Limpopo 
•  Free State 
•  Mpumalanga 
•  Northern Cape 
•  Western Cape 
SECTION 2. KNOWLEDGE 
How important are the following sources of antibiotic 
information in determining your choice of antibiotic for 
clinical use? * 
















































































      
Veterinary 












      
Applicatio
ns on a 
smartphon
e or tablet 








For each of the following antibiotics, please indicate if 
they are used as first, second or third line agents. * 
Please choose the appropriate response for each item: 












     
Amoxicillin 
clavulanate      
Amikacin 
     
Oxytetracycline 
     
Metronidazole 
     
Enrofloxacin 
     
Procaine 
penicillin      
Cefovecin 
     
Trimethoprim 
sulphonamide      
Gentamicin 
     
Vancomycin 
     
Clindamycin 
     
Chloramphenicol 
     
Cephalexin 
     
Marbofloxacin 
     
Rifampicin 
     
Do the following conditions require antibiotic 
therapy? * 
Please choose the appropriate response for each item: 
  Yes No Not Applicable 
Diarrhea? 
   
Fever? 
   
Urinary tract 
infection?    
Skin infection? 
   
Respiratory 
infection?    
Ecto-parasite 
infestation?    
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  Yes No Not Applicable 
Parasitic- 
gastroenteritis?    
Which of these is true about antibiotic resistance? * 
Please choose the appropriate response for each item: 
  TRUE FALSE NOT APPLICABLE 























   
Antibiotic 
resistance is 
not an issue 
in South 
Africa 
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Antibiotics 
should not 
be stored for 
later use in 
animals 




























   
Antibiotic 
resistance is 
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In your opinion, which of the following contributes to 
antibiotic resistant infections in people? * 
Please choose all that apply: 
•  Antibiotic use in human medicine 
•  Antibiotic use in small animal veterinary medicine 
•  Antibiotic use in food animal veterinary medicine 
•  Environmental pressure 
•  Random genetic mutations 
•  Not Applicable 
• Other:  
 Select any of the following factors in veterinary 
medicine that you believe may play a role in antibiotic 
resistant infections in people * 
Please choose all that apply: 
•  Client non-compliance when giving antibiotics to their animals 
•  Clients’ expectation of receiving antibiotics for their animals 
•  Over prescribing of antibiotics to animals 
•  Inadequate dose, frequency or duration of antibiotics prescribed to animals 
•  The use of medically important antibiotics (i.e. those used in human medicine) in veterinary 
medicine. 




•  Not enough evidence to link antibiotic use in veterinary medicine and antibiotic resistance in 
people 
•  Not Applicable 
• Other:  
 Please indicate how strongly you agree with each of 
the following statements * 

































      







      












To what extent did your veterinary training alone, 
adequately equip you with knowledge on rational use 
of antibiotics? * 
Please choose only one of the following: 
•  Not at all 
•  A little 
•  Somewhat 
•  Quite a bit 
•  Very much 
•  Not Applicable 
Would you be interested in obtaining continuing 
professional education (CPD) pertaining to antibiotic 
use/resistance or stewardship?  
* 
Please choose only one of the following: 
•  Yes 
•  No 
•  Not sure 







SECTION 3. ATTITUDES 
Which one of the following best represents your 
opinion about antibiotic use at your 
clinic/practice/institute? * 
Please choose only one of the following: 
•  Antibiotics are sometimes prescribed based on no documented evidence of infection. 
•  Antibiotics are sometimes prescribed for suspected (but not confirmed) infections. 
•  Antibiotics are prescribed based only on confirmed infection. 
•  Not sure 
•  Not Applicable 
Which one of the following best represents your 
opinion about antibiotic prescription at your 
practice/clinic/institute? * 
Please choose only one of the following: 
•  Antibiotics are under prescribed 
•  Antibiotics are optimally prescribed 
•  Antibiotics are over-prescribed 
•  Not Applicable 
How do you rate your degree of concern about 
antibiotic resistant infections? * 
Please choose only one of the following: 
•  Not concerned 
•  Slightly concerned 
•  Moderately concerned 
•  Quite concerned 
•  Very concerned 
•  Not Applicable 
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To what extent do you agree or disagree with the 
following statement? “Antibiotic classes commonly 
used in human medicine should not be used in 
veterinary medicine because their use in veterinary 
medicine selects for antibiotic resistance in bacteria 
that can cause infections in humans. * 
Please choose only one of the following: 
•  Strongly disagree 
•  Disagree 
•  Neither disagree nor agree 
•  Agree 
•  Strongly Agree 
•  Not Applicable 
To what extent do you agree or disagree with the 
following statement? "Antibiotic drug use in veterinary 
practice may lead to antibiotic resistance in pathogens 
affecting humans." 
* 
Please choose only one of the following: 
•  Strongly disagree 
•  Disagree 
•  Neither disagree nor agree 
•  Agree 
•  Strongly agree 
•  Not Applicable 
Which of the following factors in veterinary medicine 
pose a challenge to implementing and using an 
antibiotic stewardship plan (i.e., a protocol for 
judicious antibiotic use)? (Select all that apply) * 
Please choose all that apply: 
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•  Client expectations of receiving antibiotics 
•  Time required for adequate client education 
•  Practice culture 
•  Cost of diagnostics (i.e. bacterial culture/sensitivity) 
•  Time to results of diagnostics (i.e. bacterial culture/sensitivity) 
•  Current low rates of antibiotic prescribing 
•  Antibiotic stewardship plans are not needed in veterinary medicine 
•  There are no barriers to antibiotic stewardship plans in veterinary medicine 
•  Not Applicable 
• Other:  
How often do you discuss antibiotic resistance with 
your clients? * 
Please choose only one of the following: 
•  Never 
•  Rarely 
•  Sometimes 
•  Often 
•  Always 
•  Not Applicable 
How do you rate the majority of your clients’ concerns 
about antibiotic resistance? * 
Please choose only one of the following: 
•  Not concerned 
•  Slightly concerned 
•  Moderately concerned 
•  Quite concerned 
•  Very concerned 
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•  Not Applicable 
SECTION 4. PRACTICES AND 
EXPERIENCES 
What are the 3 most important factors that would 
influence your decision to submit samples for culture 
and sensitivity testing? * 
Please choose all that apply: 
•  Location of the infection 
•  Ease of obtaining a sample 
•  Persistent infection 
•  Severe infection 
•  Client finances 
•  Unusual infection 
•  Atypical cytology 
•  To confirm a diagnosis 
•  Herd problems 
•  Recurring infections 
•  Not applicable 








How important are the following factors in determining 
your choice of antibiotic for clinical use? * 





























on the animal 









      
Cost 











      
Route of 
administration       
Frequency of 
administration       
Medication size 

















































      
Fear of 
litigation by the 
client/producer 




      
Concerns about 
animal welfare       
Prudent use 

















How frequently do you read veterinary guidelines for 
judicious use of antibiotics? * 
Please choose only one of the following: 
•  Never 
•  Rarely 
•  Sometimes 
•  Very often 
•  Always 
•  Not Applicable 
How often do you prescribe antibiotics for therapeutic 
treatment of infectious diseases in your clinical 
setting? * 
Please choose only one of the following: 
•  Never 
•  Once a day 
•  2 times a day 
•  3 - 5 times a day 
•  > 5 times a day 
•  Not Applicable 
How often do you prescribe antibiotics for 
metaphylaxis? * 
Please choose only one of the following: 
•  Never 
•  Once a day 
•  2 times a day 
•  3 - 5 times a day 
•  > 5 times a day 
•  Not Applicable 
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How often do you prescribe antibiotics for prophylaxis 
of infectious diseases? * 
Please choose only one of the following: 
•  Never 
•  Once a day 
•  2 times a day 
•  3 - 5 times a day 
•  > 5 times a day 
•  Not Applicable 
How often do you prescribe antibiotics for pre-
operative prophylaxis of infections? * 
Please choose only one of the following: 
•  Never 
•  1 - 2 cases out of every 10 surgical patients 
•  3 - 5 cases out of every 10 surgical patients 
•  6 - 8 cases out of every 10 surgical patients 
•  > 8 cases out of every 10 surgical patients 
•  Not Applicable 
How often do you prescribe antibiotics to prevent post-
operative infections? * 
Please choose only one of the following: 
•  Never 
•  1 - 2 cases out of every 10 surgical patients 
•  3 - 5 cases out of every 10 surgical patients 
•  6 - 8 cases out of every 10 surgical patients 
•  > 8 cases out of every 10 surgical patients 
•  Not Applicable 
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How often do you prescribe the following classes of 
antibiotics? * 

















des       
Cephalosporin
s       
Fluoroquinolo
nes       
Lincosamides 
      
Macrolides 
      
Penicillins 
      
Sulfas 
      
Tetracyclines 
      
Have you ever prescribed or administered any of the 
following antibiotics (Select all that apply)? * 
Please choose all that apply: 
•  Imipenem 
•  Linezolid 
•  Polymyxin B (Terra-cortril® and or Surolan®) 
•  Vancomycin 
•  No, I have not prescribed or administered any of these antibiotics 
•  Unsure 
•  Not Applicable 
What are the 5 antibiotic drugs that you commonly 
prescribe? (Rank from the most to the least.) 





Please write your answer here: 
  
For each of the following scenarios please indicate the 
level of biosecurity you would take for examination and 
performing procedures. * 























examination of a 
dog or cat 
      
Routine 
examination of a 
horse 
      
Routine 
examination of a 
cow 
      
Horse with fever 
of unknown origin 
and neurological 
signs 
      
Horse with acute 
watery diarrhoea       
Cow with acute 
watery diarrhoea       
Respiratory signs 
of 4 days duration 
in an otherwise 
healthy cat 
      
Postmortem 
examination of a 
cow 
      
Postmortem 
examination of a 
horse 
      
Aborted foetal 
material from a 
horse 
      
Routine dental 
prophylaxis in a 
dog 
























Cow with dystocia 
      
Goats with poor 
conception rates       
Mare with 






      




      
When entering a 
pig farm       
Antibiotic stewardship programmes are coordinated 
interventions designed to improve and measure the 
appropriate use of antibiotics by promoting the 
selection of optimal antibiotic regimens, dose, and 
duration of therapy and route of administration. Does 
your practice/clinic/institute have an antibiotic 
stewardship program? * 
Please choose only one of the following: 
•  No 
•  Not sure 
•  Yes 





If your answer was no above, do you think that your 
practice should develop and implement an antibiotic 
stewardship program? 
Please choose only one of the following: 
•  Yes 
•  No 
•  Not sure 
•  Not Applicable 
Thank you for your participation. 
11-04-2019 – 12:08 
 
Submit your survey. 

























Table S3A. Association between socio-demographic factors and selected knowledge variables. 
Factor Knowledge of antibiotic resistance  Opinion on contributors to antibiotic 
resistant infections in people.  
Selection of factors in veterinary medicine 
playing a role in antibiotic resistant infections in 
people 
Mean (+/- SD) Independent t-
test/ANOVA P 
value 
Mean (+/- SD) Independent t-
test/ANOVA P value 
Mean (+/- SD) Independent t-
test/ANOVA P value 
Gender            
 
           I0.447  
  
 












11.47(1.25) 2.04(1.02) 4.11(0.99) 
Age   
                      
                 I0.213 
  
 
                  I0.148 
  
                                                        
I0.918 
 
20-40 years  
 
11.81(1.00) 1.75(1.08) 3.97(1.20) 












                  A0.206 
  
 
                                                           
A0.157 
 
0-10years  11.82(1.00) 1.74(1.05) 3.94(1.18) 
11-20years  11.17(1.69) 1.94(1.30) 3.50(1.25) 
+ 20years  11.54(1.37) 2.18(1.10) 4.12(1.12) 
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Place of practice  
 
           
 
          I0.004*                             
  
 






Rural 11.08(1.67) 2.13(1.12) 3.76(1.28) 




Table S3B: Association between socio-demographic factors and selected knowledge variables. 
Factor Importance of sources of antibiotic information in 
determining choice of antibiotic for clinical use 
Knowledge of antibiotic stewardship, antibiotic resistance 
mechanisms, and pharmacology. 
Mean (+/- SD) Independent t-test/ANOVA P 
value 
Mean (+/- SD) Independent t-test/ANOVA P 
value 
Gender            
 
              I0.524  
  
 








Age   
                      
                        I0.833 
 
 
                                I0.125 
 
20-40 years  
 
5.44(2.11) 3.13(1.10) 
+40 years 5.53(1.98) 3.43(0.83) 









                               A0.136 
0-10years  5.47(2.06) 3.15(1.08) 
11-20years  4.67(2.25) 3.17(1.10) 
+ 20years  5.82(1.83) 3.52(0.71) 
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Place of practice  
 
           
 
                 I0.804    
  
 
                    I0.420 
 
Rural 5.45(1.97) 3.24(1.00) 








The extent to which veterinary training alone 
adequately equipped veterinarians with knowledge 
on the rational use of antibiotics. 
Chi-square P-value 
 
Not at all/a little Somewhat Quite a bit/very 
much 
 N % N % N %  
Gender        
Female 2 5.9 8 23.5 24 70.6 
0.103 
Male 1 2.5 3 7.5 36 90 
Age        
20-40 0 0 2 11.1 16 88.9 
0.504 
+40 3 5.4 9 16.1 44 78.6 
Veterinary experience        
0-10 years 0 0 2 11.1 16 88.9 
 
0.498 
11-20 years 0 0 2 12.5 14 87.5 
+ 20 years 3 7.5 7 17.5 30 75 
Place of practice        
Rural 0 0 3 12.5 21 87.5 
0.416 
Urban 3 6 8 16.0 39 78 
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Table S4. Association between socio-demographic factors and selected attitude variables. 




 Antibiotics are 
sometimes 
prescribed for 

















 N % N % N %  
Gender        
Female 37 75.5 8 16.3 4 8.2 
0.553 
Male 44 83 7 13.2 2 3.8 
Age        
20-40 27 84.4 4 12.5 1 3.1 
0.637 
+40 54 77.1 11 15.7 5 7.1 
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Veterinary experience        
0-10 years 29 85.3 4 11.8 1 2.9 
0.682 11-20 years 14 77.8 2 11.1 2 11.1 
+20 years 38 76 9 18 3 6 
Place of practice        
Rural 29 76.3 8 21.1 1 2.6 
0.244 
Urban 52 81.3 7 10.9 5 7.8 
 Opinion about antibiotic prescription at 
clinic/practice/institute 
 









 N % N % N %  
Gender        
Female 24 49 1 2 24 49 
0.335 
Male 21 39.6 0 0 32 60.4 
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Age        
20-40 15 46.9 0 0 17 53.1 
0.754 
+40 30 42.9 1 1.4 39 55.7 
Veterinary experience        
0-10 years 15 44.1 0 0 19 55.9 
0.312 11-20 years 8 44.4 1 5.6 9 50 
+20 years 22 44 0 0 28 56 
Place of practice       
0.252 Rural 14 36.8 1 2.6 23 60.5 
Urban 31 48.4 0 0 33 51.6 
 The extent of agreeing on antibiotic use in veterinary 










 N % N % N %  
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Gender        
Female 6 12.2 7 14.3 36 73.5 
0.901 
Male 8 15.1 8 15.1 37 69.8 
Age        
20-40 3 9.4 5 15.6 24 75 
0.688 
+40 11 15.7 10 14.3 49 70 
Place of practice        
Rural 6 15.8 5 13.2 27 71.1 
0.865 
Urban 8 12.5 10 15.6 46 71.9 












Gender        
Female 1 4.2 3 12.5 20 83.3 
0.563 
Male 0 0 4 17.4 19 82.6 
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Age        
20-40 0 0 1 6.7 14 93.3 
0.416 
+40 1 3.1 6 18.8 25 78.1 
Veterinary experience        
0-10 years 0 0 1 6.3 15 93.8 
0.053 11-20 0 0 5 38.5 8 61.5 
+20 years 1 5.6 1 5.6 16 88.9 
        
Place of practice        
Rural 1 5.9 2 11.8 14 82.4 
0.379 
Urban 0 0 5 16.7 25 83.3 










 N % N % N %  
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Veterinary experience        
0-10 years 18 54.5 10 30.3 5 15.2 
0.332 11-20 years 8 47.1 6 35.3 3 17.6 
+20 years 15 31.3 22 45.8 11 22.9 
Age        
20-40 16 51.6 10 32.3 5 16.1 
0.410 
+40 25 37.3 28 41.8 14 20.9 
Place of practice        
Rural 17 45.9 12 32.4 8 21.6 
0.604 
Urban 24 39.3 26 42.6 11 18 
 The extent of agreeing on the statement “Antibiotic 
classes commonly used in human medicine should 
not be used in veterinary medicine because 


















Gender        
Female 8 26.7 13 43.3 9 30 
0.509 
Male 9 25.7 11 31.4 15 42.9 
Age        
20-40 3 13.6 10 45.5 9 40.9 
0.248 
+40 14 32.6 14 32.6 15 34.9 
Veterinary experience        
0-10 years 4 16.7 11 45.8 9 37.5 
0.078 11-20 years 3 37 5 62.5 0 0 
+20 years 10 30.3 8 24.2 15 45.5 
Place of practice        
Rural 7 25 9 32.1 12 42.9 
0.671 
Urban 10 27 15 40.5 12 32.4 
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Table S5A: Association between socio-demographic factors and selected practice variables. 
Factor Frequency of prescribing classes of 
antibiotics 
Frequency of prescribing antibiotics 
for therapeutic treatment of infectious 
diseases in the clinical setting 
Importance of factors in determining choice 
of antibiotic for clinical use 
Mean (+/- SD) Independent t-
test/ANOVA P 
value 
Mean (+/- SD Independent t-
test/ANOVA P 
value 
Mean (+/- SD Independent t-















2.68(1.27) 2.58(1.05) 9.92(3.81) 
Age   
                      
               I0.844 
    
20-40 years  
 
2.56(1.01) 2.62(0.98) 
                 I0.919 
9.88(3.89) 
                       I0.677 
+40 years 2.61(1.31) 2.60(1.06) 10.23(4.00) 





         A0.112 
    
0-10years  5.47(2.06) 2.65(0.99) 
               A0.707 
9.74(3.91) 
                      A0.315 11-20years  4.67(2.25) 2.40(0.99) 9.22(4.76) 
+ 20years  5.82(1.83) 2.64(1.09) 10.70(3.64) 
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Place of practice  
 
           
 
      
    
Rural 2.68(1.25) 
             I0.585 
2.42(1.15) 
            I0.211 
10.11(3.28) 
                      I0.981 Urban 2.55(1.21) 2.71(0.96) 10.13(4.32) 
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Table S5B: Association between socio-demographic factors and selected practice variables 
Variables Frequency of reading veterinary guidelines for 
appropriate use of antibiotics 
Chi-square P value 
 Never/rarely Sometimes Very 
often/always 
 
Gender        
Female 9 18.8 23 47.9 16 33.3 
          0.104 
Male 4 7.5 22 41.5 27 50.9 
Age        
20-40 6 18.8 16 50 10 31.3 
          0.225 
+40 7 10.1 29 42 33 47.8 
Veterinary experience        
0-10 years 6 17.6 16 47.1 12 35.3 
          0.252 11-20 years 2 11.1 11 61.1 5 27.8 
+20 years 5 10.2 18 36.7 26 53.1 
Place of practice        
Rural 5 13.2 17 44.7 16 42.1 
          0.996 
Urban 8 12.7 28 44.4 27 42.9 
 Frequency of discussing antibiotic resistance with 
clients 
 
 Never/rarely Sometimes Often/always  
Gender        
Female 8 16.7 15 31.3 25 52.1 
          0.378 
Male 4 7.7 19 36.5 29 55.8 
Age        
20-40 4 12.5 9 28.1 19 59.4           0.691 
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+40 8 11.8 25 36.8 35 51.5 
Veterinary experience        
0-10 years 4 11.8 10 29.4 20 58.8 
          0.555 11-20 years 4 22.2 10 55.6 4 22.2 
+20 years 4 8.3 14 29.2 30 62.5 
 Client finances as an influence on the decision to 
submit samples for culture and sensitivity 
 
 No Yes  
 N % N %  
Place of practice      
Rural 19 50 19 50 
0.647 
Urban 35 54.7 29 45.3 
 Recurring infections as an influence on the decision 
to submit samples for culture and sensitivity 
 
 No Yes  
Gender      
Female 13 26.5 36 73.5 
0.682 
Male 16 30.2 37 69.8 
      
Age      
20-40 5 15.6 27 84.4 
0.053 
+40 24 34.3 46 65.7 
Veterinary experience      
0-10 years 5 14.7 29 85.3 
0.057 
11-20 years 8 44.4 10 55.6 
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+20 years 16 32 34 68 
Place of practice      
Rural 9 23.7 29 76.3 
0.413 
Urban 20 31.3 44 68.8 
 Persistent infection as an influence on the decision to 
submit samples for culture and sensitivity 
 
 No Yes  
Gender      
Female 5 10.2 44 89.8 
0.459 
Male 8 15.1 45 84.9 
      
Age      
20-40 4 12.5 28 87.5 
0.960 
+40 9 12.9 61 87.1 
Veterinary experience      
0-10 years 4 11.8 30 88.2 
0.511 11-20 years 1 5.6 17 94.4 
+20 years 8 16 42 84 
Place of practice      
Rural 8 21.1 30 78.9 
0.053 












CONCLUSIONS, LIMITATIONS, AND RECOMMENDATIONS 
3.1 CONCLUSIONS  
A quantitative questionnaire-based online survey was conducted to determine the knowledge, attitudes 
and practices of veterinarians on antibiotic use, ABR, and its containment in the South African 
veterinary sector.  
3.1.1 Knowledge  
Concerning knowledge on antibiotic use, ABR, and its containment, the following conclusions were 
drawn. From the results, the average scores on knowledge on antibiotic resistance were very good.  
Based on a total score of 13, the average score for the respondents was 11.57± 1.33). Veterinarians in 
urban practice were more knowledgeable about antibiotic resistance (11.86±1.00) compared to those 
in rural practice (11.08±1.67). The average score on contributors to antibiotic resistant infections in 
people was low (Based on a total score of 5, the respondents’ average score was 1.99±1.13). The 
average score on selecting factors in veterinary medicine that may play a role in antibiotic resistant 
infections in people was good (Based on a total score of 7, the average score for the respondents was 
3.95±1.17). Self-reported knowledge on antibiotic stewardship, antibiotic resistance mechanisms, and 
pharmacology was good (96 (94.1%), 91 (89.2%), and 70 (68.6%), respectively). To a greater extent, 
veterinary training alone adequately equipped veterinarians with knowledge of antibiotics’ rational 
use (More than half the respondents 60 (58.8%) were confident that veterinary training prepared them 
quite a bit/very much). The veterinary formulary, peer-reviewed scientific literature, and textbooks or 
drug handbooks were considered to be the most important sources of information on antibiotics (83 
(81.4%), 82 (80.4%), and 80 (78.5%) respectively). A majority of veterinarians identified the narrow-
spectrum antibiotics amoxicillin and procaine penicillin as first-line treatment (79 (77.5 %) and 50 
(49%) respectively). Some respondents also identified broad-spectrum antibiotics such as amoxicillin-
clavulanate and metronidazole as first-line treatment (62 (60.8%) and 64 (62.7%) respectively). 
Penicillins were often prescribed (70.6%), with amoxicillin-clavulanate and procaine penicillin being 
the preferred antibiotics in that class (49 (48%) and 27 (26.5%), respectively).  
3.1.2 Attitudes   
Notably, most of the respondents believed that antibiotics were sometimes prescribed for suspected 
but not confirmed infections 81 (79.4%). A little more than half of the respondents believed that 
antibiotics were optimally prescribed 56 (54.9%). The concern related to antibiotic resistant infections 
amongst veterinarians was inverted amongst their clients. The majority of the respondents were quite 
concerned/very concerned about antibiotic resistant infections 77 (75.5%) compared to 19 (18.7%) of 
clients expressing the same concern. Impressively, most of the respondents agreed/strongly agreed 
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that antibiotic drug use in veterinary practice might lead to antibiotic resistance in pathogens affecting 
humans 73 (71.5%). In contrast, only 24 (23.5%) agreed/strongly agreed that the antibiotic classes 
commonly used in human medicine should not be used in veterinary medicine as they select for 
antibiotic resistant bacteria. The cost of diagnostics (90 [88.2]), time to results of diagnostics (83 
[81.4%]), and client expectations of receiving antibiotics (74 [72.5%]) were cited the most as barriers 
to the implementation and use of an antibiotic stewardship plan in veterinary medicine. 
3.1.3 Practices 
Some respondents (45 [44.1%)] sometimes read veterinary guidelines for appropriate use of 
antibiotics while 43 (42.2%) did it very often/always. A little more than half the veterinarians (54 
[52.9%]) often/always discussed antibiotic resistance with their clients, with those in rural practice 
frequently doing so compared to their urban counterparts (p value=0.035). Persistent infection (89 
[87.3%]), recurring infections (73 [71.6%]), and client finances (48 [47.1%]) were the most important 
factors in influencing the decisions of veterinarians to submit samples for microbial culture and 
susceptibility testing. Most veterinarians (61 [59.8%]) lacked antibiotic stewardship programmes at 
their practices.  
3.1.4 Overall Conclusion 
From our study, gaps in the knowledge, attitudes, and practices on antibiotic use, antibiotic resistance, 
and its containment were identified. Knowledge of rational antibiotic use and ABR should be included 
in continuing professional development programmes to address such gaps in different geographical 
location. Antibiotic stewardship programmes need to be implemented in veterinary practice, cost-
effective diagnostic tests with shorter turnaround time might assist in achieving such. Antibiotic 
stewardship programmes might encourage the frequent use of guidelines for the appropriate use of 
antibiotics and microbiology informed therapy. Client education on ABR is imperative; more 
discussions between veterinarians and their clients over ABR might help change client attitudes. 
There is a need for veterinarians to use narrow-spectrum antibiotics as first-line drugs . Use of the 
OIE list of veterinary important antibiotics and the WHO list of medically important antibiotics 
should be encouraged to conserve the antibiotics of critical importance. 
3.2 LIMITATIONS 
• The South African Veterinary Council was unable to assist in sending out the survey to their 
registered members because of compliance with the Protection of Personal Information Act 
which might have affected the response rate. 
• The response rate was abysmal (6%) compared to other studies of a similar nature      
            elsewhere. Therefore, the results of the study may not be generalised to the whole    
            veterinary profession. However, the study managed to unlock areas that require      
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            further attention amongst veterinarians. 
• The survey was made available only for a month (1st of October 2019 till the 31st of October 
2019). This might have affected the response rate. 
• Only veterinarians participated in the survey. Results could have been more comprehensive if 
the other animal health professions had participated. 
 
3.3 RECOMMENDATIONS 
• Professional veterinary bodies could help in encouraging animal health professionals to 
participate in research to produce an evidence base that can efficiently inform interventions.  
• Awareness should be raised on the importance of the OIE list of veterinary important 
antibiotics and the WHO list of medically important antibiotics and the need to conserve them 
for the treatment of infections in humans and animals.  
• The use of diagnostic tests that are more cost-effective and with a shorter turnaround time 
could encourage culture and susceptibility testing and might assist in implementing antibiotic 
stewardship programmes.   
• Continuing professional development programmes should encompass rational antibiotic use 
and ABR to improve knowledge among veterinarians. 
• Veterinarians must be encouraged to raise awareness on ABR through engaging in frequent 
discussions with clients on the ABR matter. 
• Veterinarians also need to be proactive in reporting adverse antimicrobial drug events 
together with suspected lack of efficacy of antibiotics which may be related to ABR to the 
respective pharmaceutical companies. This will favour the analysis of possible ABR trends 
thus informing interventions thereof. 
 
 
 
 
 
 
 



